Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
NEU.INH_VIP.develop_niche: Meta traits — page 2
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 122 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1,001–2,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1001 | IRAG2/TBC1D23 ratio | PRORT001367 | 0.64 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 19 | |
| 1002 | COL6A3/TAFA5 ratio | PRORT000702 | 0.64 | Protein ratios | Hepatocyte | 31 | 5 | 7 | 24 | |
| 1003 | Osteomyelitis | IMMUN000068 | 0.64 | Immunologic | Stromal / connective | 19 | 2 | 4 | 5 | |
| 1004 | PPM1F levels | PROLV001611 | 0.64 | Protein levels | Lymphocyte | 9 | 3 | 8 | 21 | |
| 1005 | DSG2 levels | PROLV000655 | 0.64 | Protein levels | Epithelial | 31 | 0 | 9 | 6 | |
| 1006 | ENG levels | PROLV000704 | 0.64 | Protein levels | Adipose | 10 | 4 | 12 | 30 | |
| 1007 | NOS3 levels | PROLV001415 | 0.64 | Protein levels | Myeloid | 58 | 5 | 9 | 18 | |
| 1008 | Amyotrophic lateral sclerosis, ALS | NEURO000017 | 0.64 | Neurologic | Myeloid | 13 | 1 | 4 | 7 | |
| 1009 | MEGF9/OXT ratio | PRORT001514 | 0.63 | Protein ratios | Hepatocyte | 34 | 1 | 4 | 15 | |
| 1010 | MUC2 levels | PROLV001353 | 0.63 | Protein levels | B / plasma cell | 35 | 0 | 6 | 8 | |
| 1011 | Myasthenia gravis | IMMUN000035 | 0.63 | Immunologic | Lymphocyte | 54 | 1 | 13 | 36 | |
| 1012 | CRADD/MAP4K5 ratio | PRORT000748 | 0.63 | Protein ratios | Muscle / cardiac | 2 | 5 | 11 | 19 | |
| 1013 | Menstrual disorder | REPRO000021 | 0.63 | Reproductive | Vascular | 6 | 0 | 2 | 3 | |
| 1014 | Cervical disorder | REPRO000001 | 0.63 | Reproductive | Stromal / connective | 8 | 2 | 9 | 19 | |
| 1015 | ST6GALNAC2 levels | PROLV001954 | 0.63 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 1016 | PFKM levels | PROLV001541 | 0.63 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 1017 | POMC levels | PROLV001599 | 0.63 | Protein levels | B / plasma cell | 28 | 1 | 3 | 12 | |
| 1018 | PSCA levels | PROLV001655 | 0.62 | Protein levels | Neural / glial | 5 | 1 | 4 | 12 | |
| 1019 | Medication, anti-diabetic | METBL000024 | 0.62 | Metabolic | Hematopoietic progenitor | 156 | 1 | 3 | 7 | |
| 1020 | BCL2 levels | PROLV000185 | 0.62 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 1021 | Heart failure | CARDI000007 | 0.62 | Cardiac | Muscle / cardiac | 37 | 2 | 3 | 10 | |
| 1022 | Panic attack | PSYCH000031 | 0.61 | Psychiatric | Muscle / cardiac | 0 | 1 | 7 | 4 | |
| 1023 | COL3A1 levels | PROLV000489 | 0.61 | Protein levels | Myeloid | 15 | 4 | 10 | 22 | |
| 1024 | AHNAK levels | PROLV000062 | 0.61 | Protein levels | Lymphocyte | 17 | 2 | 12 | 33 | |
| 1025 | Cirrhosis | HPBIL000006 | 0.61 | Hepatopancreatobiliary | Neural / glial | 9 | 2 | 1 | 4 | |
| 1026 | Medication, diuretic | VASCU000038 | 0.61 | Vascular | Vascular | 21 | 1 | 5 | 16 | |
| 1027 | SEMA3F levels | PROLV001807 | 0.61 | Protein levels | Myeloid | 106 | 2 | 6 | 14 | |
| 1028 | Urinary retention | NEPHR000015 | 0.61 | Nephrourologic | Lymphocyte | 0 | 0 | 1 | 5 | |
| 1029 | Heart failure, congestive | CARDI000004 | 0.61 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 1030 | Hypothyroxinemia | ENDOC000022 | 0.60 | Endocrine | Neural / glial | 0 | 3 | 11 | 16 | |
| 1031 | CD164 levels | PROLV000313 | 0.60 | Protein levels | Myeloid | 20 | 2 | 10 | 12 | |
| 1032 | COL1A1 levels | PROLV000485 | 0.60 | Protein levels | B / plasma cell | 22 | 0 | 1 | 0 | |
| 1033 | Brugada syndrome | CARDI000020 | 0.60 | Cardiac | Muscle / cardiac | 27 | 4 | 6 | 7 | |
| 1034 | MMP8 levels | PROLV001327 | 0.60 | Protein levels | Myeloid | 7 | 2 | 7 | 8 | |
| 1035 | FABP4 levels | PROLV000754 | 0.60 | Protein levels | Stromal / connective | 8 | 0 | 3 | 6 | |
| 1036 | CA2/CA3 ratio | PRORT000274 | 0.59 | Protein ratios | Muscle / cardiac | 0 | 3 | 11 | 23 | |
| 1037 | Medication, anti-cancer | MALIG000048 | 0.59 | Malignancy | Epithelial | 9 | 0 | 5 | 9 | |
| 1038 | CKMT1A or CKMT1B levels | PROLV000442 | 0.59 | Protein levels | Gastrointestinal epithelium | 59 | 0 | 10 | 7 | |
| 1039 | NFATC1/TJAP1 ratio | PRORT001587 | 0.59 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 8 | |
| 1040 | TF levels | PROLV002011 | 0.59 | Protein levels | Hepatocyte | 40 | 3 | 8 | 17 | |
| 1041 | CA1/CA2 ratio | PRORT000267 | 0.59 | Protein ratios | Muscle / cardiac | 0 | 1 | 7 | 11 | |
| 1042 | CNTN3/FETUB ratio | PRORT000686 | 0.59 | Protein ratios | Hepatocyte | 37 | 1 | 7 | 10 | |
| 1043 | IL13RA1 levels | PROLV001047 | 0.58 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 1044 | CDH2 levels | PROLV000374 | 0.58 | Protein levels | Hepatocyte | 137 | 1 | 11 | 25 | |
| 1045 | Betaine | METAB000041 | 0.58 | Metabolites | Hepatocyte | 7 | 0 | 2 | 7 | |
| 1046 | PDLIM5 levels | PROLV001528 | 0.58 | Protein levels | Stromal / connective | 1 | 3 | 13 | 30 | |
| 1047 | ANPEP/NT5E ratio | PRORT000102 | 0.58 | Protein ratios | Vascular | 19 | 0 | 4 | 9 | |
| 1048 | DTX3 levels | PROLV000660 | 0.58 | Protein levels | Renal epithelium | 2 | 0 | 3 | 9 | |
| 1049 | GABARAPL1 levels | PROLV000844 | 0.58 | Protein levels | Hepatocyte | — | 2 | 8 | 14 | |
| 1050 | Cancer, Breast | MALIG000011 | 0.57 | Malignancy | Cutaneous epithelium | 47 | 1 | 8 | 13 | |
| 1051 | CCS levels | PROLV000307 | 0.57 | Protein levels | Lymphocyte | 50 | 2 | 13 | 44 | |
| 1052 | Erythrocyte | HEMAT000005 | 0.57 | Hematologic | Hematopoietic progenitor | 3,061 | 3 | 7 | 17 | |
| 1053 | S100A14 levels | PROLV001769 | 0.57 | Protein levels | Hepatocyte | 25 | 3 | 11 | 21 | |
| 1054 | CHMP1A/EREG ratio | PRORT000612 | 0.57 | Protein ratios | Myeloid | 33 | 3 | 14 | 21 | |
| 1055 | Lichen disorder | DERMA000013 | 0.57 | Dermatologic | Lymphocyte | 73 | 1 | 12 | 18 | |
| 1056 | Consultant specialty, general surgery | MISCL000017 | 0.57 | Miscellaneous | Neural / glial | 3 | 2 | 4 | 10 | |
| 1057 | EDAR/IRAK4 ratio | PRORT000971 | 0.56 | Protein ratios | Myeloid | 38 | 2 | 13 | 16 | |
| 1058 | HGF/MMP9 ratio | PRORT001283 | 0.56 | Protein ratios | Hepatocyte | 20 | 4 | 13 | 28 | |
| 1059 | Ventricular function | CARDI000008 | 0.56 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 1060 | ADHD | PSYCH000033 | 0.56 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 | |
| 1061 | Taurine metabolites | METAB000014 | 0.56 | Metabolites | Vascular | 8 | 0 | 1 | 1 | |
| 1062 | PDGFA/SERPINE1 ratio | PRORT001635 | 0.56 | Protein ratios | Hematopoietic progenitor | 33 | 5 | 9 | 12 | |
| 1063 | PDGFRB levels | PROLV001526 | 0.56 | Protein levels | Myeloid | 59 | 6 | 15 | 28 | |
| 1064 | Medication, analgesic or antidepressant | MISCL000033 | 0.56 | Miscellaneous | Lymphocyte | 0 | 3 | 16 | 43 | |
| 1065 | HGS levels | PROLV000967 | 0.55 | Protein levels | Stromal / connective | 0 | 3 | 11 | 17 | |
| 1066 | MCAM levels | PROLV001283 | 0.55 | Protein levels | Granulosa cell | 164 | 2 | 6 | 15 | |
| 1067 | LEPR levels | PROLV001200 | 0.55 | Protein levels | Myeloid | 79 | 3 | 10 | 26 | |
| 1068 | Peripheral artery disease | VASCU000042 | 0.55 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 1069 | Hand grip strength | MSKEL000030 | 0.55 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 1070 | CD74/IL18BP ratio | PRORT000503 | 0.55 | Protein ratios | Myeloid | 54 | 2 | 5 | 12 | |
| 1071 | S100A11 levels | PROLV001766 | 0.55 | Protein levels | Myeloid | 8 | 3 | 11 | 23 | |
| 1072 | Nucleoside metabolites | METAB000061 | 0.55 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 1073 | Arginine metabolites | METAB000003 | 0.55 | Metabolites | B / plasma cell | 3 | 0 | 1 | 2 | |
| 1074 | Ventricular mass | CARDI000012 | 0.55 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 1075 | CHI3L1/HSPG2 ratio | PRORT000610 | 0.55 | Protein ratios | Hepatocyte | 10 | 2 | 9 | 26 | |
| 1076 | EFNA4/LAYN ratio | PRORT000990 | 0.54 | Protein ratios | Muscle / cardiac | 3 | 3 | 8 | 13 | |
| 1077 | NGRN levels | PROLV001402 | 0.54 | Protein levels | Myeloid | 0 | 3 | 9 | 13 | |
| 1078 | DRG2/SEMA4D ratio | PRORT000949 | 0.54 | Protein ratios | Hepatocyte | 6 | 3 | 17 | 35 | |
| 1079 | Phosphatidylglycerols | LIPID000060 | 0.54 | Lipids | Granulosa cell | 3 | 3 | 10 | 22 | |
| 1080 | SPON2 levels | PROLV001937 | 0.54 | Protein levels | Hepatocyte | 44 | 4 | 9 | 17 | |
| 1081 | Hypothyroidism | ENDOC000021 | 0.53 | Endocrine | Lymphocyte | 371 | 1 | 12 | 20 | |
| 1082 | FLT1/TFPI2 ratio | PRORT001162 | 0.53 | Protein ratios | Myeloid | 3 | 5 | 11 | 21 | |
| 1083 | CNTNAP2 levels | PROLV000480 | 0.53 | Protein levels | Myeloid | 28 | 2 | 10 | 16 | |
| 1084 | Influenza | IMMUN000065 | 0.53 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 1085 | Coronary artery calcification | VASCU000055 | 0.53 | Vascular | Vascular | 56 | 4 | 6 | 11 | |
| 1086 | Cardiovascular disease, none | CARDI000034 | 0.53 | Cardiac | Vascular | 201 | 2 | 5 | 9 | |
| 1087 | MMP10 levels | PROLV001322 | 0.53 | Protein levels | Epithelial | 12 | 0 | 6 | 7 | |
| 1088 | EREG/GYS1 ratio | PRORT001054 | 0.52 | Protein ratios | Myeloid | 22 | 3 | 14 | 14 | |
| 1089 | SPINT2/TNFSF13 ratio | PRORT001811 | 0.52 | Protein ratios | Neural / glial | 17 | 6 | 11 | 43 | |
| 1090 | NSFL1C/PSMG3 ratio | PRORT001599 | 0.52 | Protein ratios | Neural / glial | 19 | 4 | 7 | 20 | |
| 1091 | DFFA/FOXO1 ratio | PRORT000887 | 0.52 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 22 | |
| 1092 | Connective tissue disorder | MSKEL000060 | 0.52 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 1093 | REN levels | PROLV001723 | 0.52 | Protein levels | Neural / glial | 2 | 0 | 3 | 8 | |
| 1094 | Healthspan | AGING000004 | 0.51 | Aging | Hepatocyte | 12 | 1 | 12 | 12 | |
| 1095 | Cardiovascular age gap | CARDI000001 | 0.51 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 1096 | SLIT2 levels | PROLV001887 | 0.51 | Protein levels | Neural / glial | 0 | 1 | 7 | 15 | |
| 1097 | Gut microbial abundance, Olsenella C | GASTR000030 | 0.51 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 1098 | CCL22 levels | PROLV000289 | 0.51 | Protein levels | Myeloid | 15 | 2 | 8 | 17 | |
| 1099 | KIAA0319 levels | PROLV001137 | 0.51 | Protein levels | Respiratory epithelium | 15 | 0 | 6 | 14 | |
| 1100 | Glucose levels | METBL000037 | 0.51 | Metabolic | Hepatocyte | 1,438 | 1 | 6 | 8 | |
| 1101 | MCEMP1 levels | PROLV001285 | 0.50 | Protein levels | Myeloid | 46 | 3 | 8 | 17 | |
| 1102 | PLAU/PLAUR ratio | PRORT001678 | 0.50 | Protein ratios | Muscle / cardiac | 29 | 3 | 12 | 22 | |
| 1103 | Cholesterol, non-HDL | LIPID000012 | 0.50 | Lipids | Hepatocyte | 340 | 1 | 7 | 8 | |
| 1104 | Carpal tunnel surgery | MSKEL000044 | 0.50 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 1105 | PDCD1/TNFRSF9 ratio | PRORT001631 | 0.50 | Protein ratios | Epithelial | 7 | 1 | 13 | 21 | |
| 1106 | Cancer, Oesophagus | MALIG000021 | 0.50 | Malignancy | Salivary epithelium | 1 | 0 | 2 | 4 | |
| 1107 | FNDC1 levels | PROLV000820 | 0.50 | Protein levels | Hepatocyte | 14 | 3 | 13 | 22 | |
| 1108 | ATP5IF1/FXN ratio | PRORT000157 | 0.50 | Protein ratios | Hepatocyte | 7 | 4 | 12 | 21 | |
| 1109 | TMSB10/ZBTB16 ratio | PRORT001842 | 0.50 | Protein ratios | Muscle / cardiac | 29 | 4 | 8 | 25 | |
| 1110 | Anorexia nervosa | PSYCH000011 | 0.50 | Psychiatric | Myeloid | 0 | 1 | 8 | 7 | |
| 1111 | IGFBP1 levels | PROLV001028 | 0.50 | Protein levels | Hepatocyte | 15 | 1 | 7 | 11 | |
| 1112 | Benign neoplasm, Ocular | MALIG000005 | 0.50 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 1113 | Latent factor, white cell | HEMAT000039 | 0.50 | Hematologic | Myeloid | 183 | 2 | 4 | 24 | |
| 1114 | PPP1R2/TBL1X ratio | PRORT001706 | 0.50 | Protein ratios | Myeloid | 14 | 3 | 13 | 18 | |
| 1115 | Hyperlipidaemia | METBL000022 | 0.50 | Metabolic | Hepatocyte | 381 | 1 | 7 | 7 | |
| 1116 | FGF23 levels | PROLV000796 | 0.49 | Protein levels | Myeloid | 10 | 1 | 6 | 12 | |
| 1117 | ENTPD5 levels | PROLV000713 | 0.49 | Protein levels | Myeloid | 111 | 3 | 8 | 15 | |
| 1118 | GLB1 levels | PROLV000894 | 0.49 | Protein levels | Hepatocyte | 103 | 4 | 10 | 19 | |
| 1119 | Insulin resistance | METBL000041 | 0.49 | Metabolic | Hepatocyte | 4 | 1 | 5 | 10 | |
| 1120 | METAP2/PFKFB2 ratio | PRORT001523 | 0.49 | Protein ratios | Muscle / cardiac | 1 | 3 | 9 | 18 | |
| 1121 | Secondary arthropathy | MSKEL000021 | 0.49 | Musculoskeletal | Hepatocyte | — | 2 | 9 | 13 | |
| 1122 | Polycystic ovary syndrome | REPRO000024 | 0.49 | Reproductive | Granulosa cell | 29 | 2 | 4 | 19 | |
| 1123 | DBI/MESD ratio | PRORT000862 | 0.49 | Protein ratios | Hepatocyte | 5 | 2 | 8 | 21 | |
| 1124 | CRELD2/NUCB2 ratio | PRORT000757 | 0.49 | Protein ratios | Epithelial | 38 | 1 | 6 | 15 | |
| 1125 | Medication, antihypertensive | VASCU000031 | 0.49 | Vascular | Vascular | 332 | 2 | 4 | 9 | |
| 1126 | EFNA1/PIK3IP1 ratio | PRORT000989 | 0.49 | Protein ratios | Hepatocyte | 29 | 2 | 10 | 21 | |
| 1127 | IFNGR2 levels | PROLV001021 | 0.49 | Protein levels | Myeloid | 122 | 5 | 14 | 30 | |
| 1128 | EIF4B/IPCEF1 ratio | PRORT001006 | 0.48 | Protein ratios | Muscle / cardiac | 2 | 4 | 14 | 22 | |
| 1129 | Premalignant lesion, Cervix | MALIG000036 | 0.48 | Malignancy | Lymphocyte | 36 | 1 | 8 | 27 | |
| 1130 | Fatty acids unsaturation | LIPID000032 | 0.48 | Lipids | Hepatocyte | 1,087 | 2 | 7 | 16 | |
| 1131 | CLEC1B/SNAP29 ratio | PRORT000649 | 0.48 | Protein ratios | Myeloid | 4 | 3 | 8 | 17 | |
| 1132 | Cholesterol, remnant | LIPID000013 | 0.48 | Lipids | Hepatocyte | 224 | 1 | 9 | 14 | |
| 1133 | TNFSF10 levels | PROLV002075 | 0.48 | Protein levels | Hepatocyte | 153 | 2 | 7 | 11 | |
| 1134 | ALCAM/SPINT1 ratio | PRORT000076 | 0.48 | Protein ratios | Respiratory epithelium | 41 | 1 | 7 | 13 | |
| 1135 | Pre-eclampsia | VASCU000047 | 0.48 | Vascular | Myeloid | 7 | 2 | 3 | 7 | |
| 1136 | MSRA levels | PROLV001343 | 0.48 | Protein levels | Myeloid | 18 | 2 | 4 | 15 | |
| 1137 | TLR4 levels | PROLV002044 | 0.48 | Protein levels | Lymphocyte | 0 | 1 | 6 | 23 | |
| 1138 | CA14 levels | PROLV000243 | 0.48 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 12 | |
| 1139 | Viral intestinal infection | IMMUN000077 | 0.47 | Immunologic | Hepatocyte | 3 | 1 | 5 | 11 | |
| 1140 | Thyrotoxicosis | ENDOC000024 | 0.47 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 1141 | CCL25 levels | PROLV000292 | 0.47 | Protein levels | Vascular | 127 | 0 | 2 | 11 | |
| 1142 | OSCAR/TNFRSF14 ratio | PRORT001616 | 0.47 | Protein ratios | Myeloid | 26 | 4 | 9 | 14 | |
| 1143 | Insulin sensitivity | METBL000042 | 0.47 | Metabolic | Myeloid | 1 | 1 | 3 | 8 | |
| 1144 | MOG/RTBDN ratio | PRORT001552 | 0.47 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 1145 | Glycine metabolites | METAB000007 | 0.47 | Metabolites | Hepatocyte | 13 | 1 | 2 | 12 | |
| 1146 | Lipoprotein particles, LDL | LIPID000045 | 0.47 | Lipids | Hepatocyte | 493 | 1 | 8 | 11 | |
| 1147 | Lacrimal disorder | OPHTH000020 | 0.47 | Ophthalmic | Neural / glial | 0 | 0 | 2 | 11 | |
| 1148 | Alanine | METAB000017 | 0.47 | Metabolites | Hepatocyte | 251 | 1 | 5 | 12 | |
| 1149 | SYT1 levels | PROLV001985 | 0.46 | Protein levels | Granulosa cell | 25 | 1 | 6 | 12 | |
| 1150 | Hypercholesterolaemia | METBL000021 | 0.46 | Metabolic | Hepatocyte | 462 | 1 | 7 | 8 | |
| 1151 | KIR3DL1 levels | PROLV001143 | 0.46 | Protein levels | Lymphocyte | 97 | 3 | 13 | 37 | |
| 1152 | GZMA/GZMB ratio | PRORT001257 | 0.46 | Protein ratios | Lymphocyte | 44 | 2 | 12 | 21 | |
| 1153 | RNF43 levels | PROLV001747 | 0.46 | Protein levels | Melanocyte | 0 | 1 | 1 | 3 | |
| 1154 | Cancer, Thyroid | MALIG000032 | 0.46 | Malignancy | Lymphocyte | 2 | 1 | 9 | 30 | |
| 1155 | HYOU1/RARRES2 ratio | PRORT001315 | 0.46 | Protein ratios | Hepatocyte | 29 | 3 | 7 | 14 | |
| 1156 | PCDH1 levels | PROLV001504 | 0.46 | Protein levels | Hepatocyte | 21 | 3 | 8 | 14 | |
| 1157 | MAP3K5/ZBTB16 ratio | PRORT001489 | 0.46 | Protein ratios | Muscle / cardiac | 10 | 5 | 9 | 25 | |
| 1158 | Purine metabolites | METAB000062 | 0.45 | Metabolites | Hepatocyte | 3 | 1 | 5 | 13 | |
| 1159 | PDGFB/TIMP3 ratio | PRORT001648 | 0.45 | Protein ratios | Hepatocyte | 15 | 1 | 8 | 25 | |
| 1160 | Skin pigmentation | DERMA000026 | 0.45 | Dermatologic | Melanocyte | 78 | 1 | 1 | 3 | |
| 1161 | TANK levels | PROLV001992 | 0.45 | Protein levels | Stromal / connective | 1 | 5 | 12 | 33 | |
| 1162 | CLSTN2 levels | PROLV000464 | 0.45 | Protein levels | Hepatocyte | 91 | 3 | 10 | 17 | |
| 1163 | PTPRB levels | PROLV001673 | 0.44 | Protein levels | Vascular | 89 | 3 | 11 | 17 | |
| 1164 | Sleep-related movement disorder | NEURO000016 | 0.44 | Neurologic | Pancreatic epithelium | 4 | 0 | 8 | 5 | |
| 1165 | Lipoprotein particles, HDL | LIPID000043 | 0.44 | Lipids | Hepatocyte | 1,830 | 3 | 8 | 19 | |
| 1166 | ERP29 levels | PROLV000731 | 0.44 | Protein levels | Hematopoietic progenitor | 17 | 1 | 2 | 4 | |
| 1167 | Diabetes, type 2 | METBL000034 | 0.44 | Metabolic | Hepatocyte | 723 | 0 | 3 | 5 | |
| 1168 | MDH1 levels | PROLV001289 | 0.43 | Protein levels | Myeloid | 2 | 3 | 9 | 19 | |
| 1169 | Ataxia | NEURO000013 | 0.43 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 1170 | CANT1/VSIR ratio | PRORT000310 | 0.43 | Protein ratios | Vascular | 15 | 1 | 5 | 12 | |
| 1171 | SCG2 levels | PROLV001784 | 0.43 | Protein levels | Hepatocyte | 20 | 1 | 7 | 11 | |
| 1172 | CD177 levels | PROLV000314 | 0.43 | Protein levels | Myeloid | 21 | 1 | 6 | 7 | |
| 1173 | Bacterial intestinal infection | IMMUN000052 | 0.43 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 1174 | REG4/SPINK4 ratio | PRORT001733 | 0.43 | Protein ratios | Myeloid | 0 | 0 | 2 | 10 | |
| 1175 | CD58/IL10RB ratio | PRORT000474 | 0.43 | Protein ratios | Myeloid | 4 | 2 | 5 | 7 | |
| 1176 | CD40LG/MPIG6B ratio | PRORT000452 | 0.43 | Protein ratios | Myeloid | 0 | 4 | 12 | 17 | |
| 1177 | EREG/TIMP3 ratio | PRORT001059 | 0.43 | Protein ratios | Myeloid | 5 | 2 | 13 | 18 | |
| 1178 | AIFM1/PLXNA4 ratio | PRORT000060 | 0.43 | Protein ratios | Hepatocyte | 9 | 2 | 10 | 26 | |
| 1179 | Lyme borreliosis induced IL6 expression | IMMUN000067 | 0.43 | Immunologic | Muscle / cardiac | 0 | 2 | 6 | 12 | |
| 1180 | Noninfective gastroenteritis and colitis | GASTR000013 | 0.43 | Gastrointestinal | Myeloid | 78 | 2 | 14 | 27 | |
| 1181 | NEFL levels | PROLV001389 | 0.42 | Protein levels | Hepatocyte | 16 | 2 | 7 | 16 | |
| 1182 | ANXA3 levels | PROLV000107 | 0.42 | Protein levels | Myeloid | 30 | 4 | 7 | 12 | |
| 1183 | Memory disorder | PSYCH000006 | 0.42 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 1184 | Atrioventricular block | CARDI000028 | 0.42 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 1185 | MENT levels | PROLV001296 | 0.42 | Protein levels | Hepatocyte | 57 | 2 | 10 | 14 | |
| 1186 | HGF/TNFSF14 ratio | PRORT001286 | 0.42 | Protein ratios | Hepatocyte | 19 | 5 | 14 | 27 | |
| 1187 | Dyslipidaemia | METBL000020 | 0.42 | Metabolic | Hepatocyte | 416 | 1 | 6 | 10 | |
| 1188 | RGS18 levels | PROLV001731 | 0.42 | Protein levels | Myeloid | 1 | 3 | 8 | 14 | |
| 1189 | ANXA10 levels | PROLV000105 | 0.42 | Protein levels | Myeloid | 9 | 0 | 4 | 4 | |
| 1190 | GRAP2/PTPN6 ratio | PRORT001244 | 0.42 | Protein ratios | Hepatocyte | 6 | 2 | 7 | 12 | |
| 1191 | Amino acid metabolites | METAB000002 | 0.41 | Metabolites | Neural / glial | 0 | 0 | 7 | 11 | |
| 1192 | Sputum production | RESPI000033 | 0.41 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 1193 | KRT8 levels | PROLV001168 | 0.41 | Protein levels | Adipose | 0 | 0 | 3 | 3 | |
| 1194 | NSFL1C/RILP ratio | PRORT001600 | 0.41 | Protein ratios | Neural / glial | 57 | 6 | 11 | 31 | |
| 1195 | CALB2 levels | PROLV000254 | 0.41 | Protein levels | Pancreatic epithelium | 0 | 1 | 6 | 12 | |
| 1196 | CLK2 levels | PROLV000460 | 0.41 | Protein levels | Hepatocyte | 11 | 2 | 7 | 20 | |
| 1197 | EGFR levels | PROLV000687 | 0.41 | Protein levels | Adipose | 22 | 3 | 10 | 13 | |
| 1198 | TNF/TNFRSF1B ratio | PRORT001844 | 0.40 | Protein ratios | Myeloid | 28 | 3 | 19 | 28 | |
| 1199 | Financial satisfaction | SOCIO000024 | 0.40 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 1200 | CCL4 levels | PROLV000297 | 0.40 | Protein levels | Myeloid | 72 | 2 | 5 | 8 | |
| 1201 | GYS1/PPP1R2 ratio | PRORT001255 | 0.40 | Protein ratios | Melanocyte | 0 | 1 | 5 | 12 | |
| 1202 | CDH2/SSC4D ratio | PRORT000553 | 0.40 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 14 | |
| 1203 | Female genital dysplasia | REPRO000007 | 0.40 | Reproductive | Hepatocyte | 17 | 2 | 8 | 22 | |
| 1204 | CLEC4G/MERTK ratio | PRORT000661 | 0.40 | Protein ratios | Myeloid | 78 | 5 | 18 | 29 | |
| 1205 | Phospholipids, LDL | LIPID000050 | 0.40 | Lipids | Hepatocyte | 1,023 | 1 | 6 | 12 | |
| 1206 | SPARC/TJAP1 ratio | PRORT001807 | 0.40 | Protein ratios | Myeloid | 0 | 1 | 7 | 10 | |
| 1207 | Corneal keratometry | OPHTH000006 | 0.40 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 1208 | CFD levels | PROLV000412 | 0.40 | Protein levels | Myeloid | 9 | 0 | 6 | 14 | |
| 1209 | IL22RA2 levels | PROLV001067 | 0.40 | Protein levels | Myeloid | 0 | 2 | 13 | 12 | |
| 1210 | CSF1/SEMA3F ratio | PRORT000779 | 0.39 | Protein ratios | Hepatocyte | 29 | 1 | 7 | 13 | |
| 1211 | PHOSPHO1 levels | PROLV001551 | 0.39 | Protein levels | Muscle / cardiac | 5 | 1 | 6 | 12 | |
| 1212 | PMVK/RHOC ratio | PRORT001694 | 0.39 | Protein ratios | Vascular | 0 | 2 | 9 | 10 | |
| 1213 | DNAJC9 levels | PROLV000636 | 0.39 | Protein levels | Muscle / cardiac | 1 | 2 | 11 | 35 | |
| 1214 | Total lipids, LDL | LIPID000076 | 0.39 | Lipids | Hepatocyte | 379 | 1 | 7 | 9 | |
| 1215 | Spondyloarthritis | IMMUN000044 | 0.39 | Immunologic | Myeloid | 110 | 4 | 8 | 20 | |
| 1216 | Brain neuroimaging feature | NIMAG000005 | 0.39 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 1217 | CTSC/PLA2G15 ratio | PRORT000798 | 0.39 | Protein ratios | Hepatocyte | 20 | 1 | 10 | 34 | |
| 1218 | SERPINE1/SMAD1 ratio | PRORT001777 | 0.39 | Protein ratios | Myeloid | 4 | 4 | 14 | 28 | |
| 1219 | ACADSB levels | PROLV000009 | 0.39 | Protein levels | Neural / glial | 22 | 4 | 10 | 20 | |
| 1220 | Macular degeneration | OPHTH000036 | 0.39 | Ophthalmic | Hepatocyte | 106 | 2 | 7 | 15 | |
| 1221 | Amygdala volume | NIMAG000014 | 0.39 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 1222 | Sugar alcohols | METAB000037 | 0.39 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 1223 | Haemoglobin | HEMAT000007 | 0.39 | Hematologic | Hepatocyte | 2,197 | 1 | 4 | 10 | |
| 1224 | Rheumatoid arthritis, RA | IMMUN000019 | 0.38 | Immunologic | Lymphocyte | 250 | 2 | 16 | 11 | |
| 1225 | Tenosynovitis | MSKEL000071 | 0.38 | Musculoskeletal | Myeloid | 0 | 2 | 8 | 10 | |
| 1226 | PCDH1/TNFRSF11A ratio | PRORT001623 | 0.38 | Protein ratios | Myeloid | 1 | 1 | 4 | 11 | |
| 1227 | SFRP1 levels | PROLV001844 | 0.38 | Protein levels | Vascular | 20 | 3 | 6 | 17 | |
| 1228 | CD93/CLEC14A ratio | PRORT000531 | 0.38 | Protein ratios | Neural / glial | 3 | 2 | 8 | 17 | |
| 1229 | ESAM/LAMA4 ratio | PRORT001063 | 0.38 | Protein ratios | Vascular | 16 | 4 | 9 | 15 | |
| 1230 | GLT25D1 levels | PROLV000899 | 0.38 | Protein levels | Vascular | 0 | 1 | 4 | 5 | |
| 1231 | Cancer, Small intestine | MALIG000029 | 0.38 | Malignancy | Neural / glial | 1 | 1 | 5 | 6 | |
| 1232 | IL18R1 levels | PROLV001056 | 0.38 | Protein levels | Hepatocyte | 88 | 1 | 5 | 7 | |
| 1233 | Endometriosis | REPRO000005 | 0.38 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 1234 | INPP1 levels | PROLV001089 | 0.37 | Protein levels | Stromal / connective | 0 | 2 | 6 | 19 | |
| 1235 | CRKL/SERPINB1 ratio | PRORT000767 | 0.37 | Protein ratios | Myeloid | 1 | 5 | 15 | 18 | |
| 1236 | Gut microbial abundance, CAG-776 | GASTR000023 | 0.37 | Gastrointestinal | Neural / glial | 0 | 2 | 4 | 16 | |
| 1237 | ENO2/SCRN1 ratio | PRORT001030 | 0.37 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 2 | 4 | |
| 1238 | AXIN1/ITGB1BP2 ratio | PRORT000173 | 0.37 | Protein ratios | Myeloid | 19 | 5 | 16 | 18 | |
| 1239 | Biventricular shape | CARDI000010 | 0.37 | Cardiac | Muscle / cardiac | 44 | 2 | 4 | 12 | |
| 1240 | Asparagine | METAB000018 | 0.37 | Metabolites | Hepatocyte | 6 | 2 | 10 | 14 | |
| 1241 | DAB2/FKBP5 ratio | PRORT000837 | 0.37 | Protein ratios | Hepatocyte | 22 | 5 | 12 | 16 | |
| 1242 | PPP2R2A levels | PROLV001618 | 0.37 | Protein levels | Lymphocyte | 0 | 3 | 9 | 29 | |
| 1243 | ADAMTS8/FAP ratio | PRORT000026 | 0.37 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 1244 | NUDT2 levels | PROLV001454 | 0.37 | Protein levels | Myeloid | 0 | 2 | 7 | 10 | |
| 1245 | PDCD6 levels | PROLV001518 | 0.37 | Protein levels | Muscle / cardiac | 54 | 3 | 13 | 24 | |
| 1246 | PDGFB levels | PROLV001523 | 0.37 | Protein levels | Myeloid | 60 | 3 | 12 | 14 | |
| 1247 | Gut microbial abundance, Flavonifractor | GASTR000025 | 0.37 | Gastrointestinal | Granulosa cell | 0 | 0 | 2 | 4 | |
| 1248 | Upper gastrointestinal disorder | GASTR000054 | 0.37 | Gastrointestinal | Myeloid | 0 | 1 | 7 | 13 | |
| 1249 | CDKN1A/PLA2G4A ratio | PRORT000571 | 0.36 | Protein ratios | Vascular | 14 | 4 | 12 | 23 | |
| 1250 | Gastric ulcer | GASTR000048 | 0.36 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 1251 | RILP levels | PROLV001734 | 0.36 | Protein levels | Lymphocyte | 22 | 2 | 15 | 42 | |
| 1252 | PFDN5 levels | PROLV001539 | 0.36 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 1253 | CDKN1A/TMSB10 ratio | PRORT000574 | 0.36 | Protein ratios | Hepatocyte | 31 | 2 | 13 | 28 | |
| 1254 | CSF volume | NIMAG000018 | 0.36 | Neuroimaging | Stromal / connective | 16 | 2 | 2 | 6 | |
| 1255 | GUCA2A levels | PROLV000945 | 0.36 | Protein levels | Pancreatic epithelium | 28 | 0 | 5 | 5 | |
| 1256 | LY75 levels | PROLV001248 | 0.36 | Protein levels | Myeloid | 56 | 2 | 6 | 16 | |
| 1257 | CEP112 levels | PROLV000399 | 0.36 | Protein levels | Neural / glial | 0 | 2 | 5 | 11 | |
| 1258 | AXL/GAS6 ratio | PRORT000179 | 0.36 | Protein ratios | Myeloid | 29 | 3 | 9 | 19 | |
| 1259 | AGR2 levels | PROLV000055 | 0.36 | Protein levels | Pancreatic epithelium | 26 | 0 | 8 | 13 | |
| 1260 | Neurological disorder | NEURO000008 | 0.35 | Neurologic | Muscle / cardiac | 0 | 1 | 7 | 7 | |
| 1261 | Diabetes, type 1 with complication | IMMUN000011 | 0.35 | Immunologic | Neural / glial | 14 | 0 | 2 | 7 | |
| 1262 | Liver fibrosis and cirrhosis | HPBIL000007 | 0.35 | Hepatopancreatobiliary | B / plasma cell | 11 | 4 | 13 | 32 | |
| 1263 | Total lipids, HDL | LIPID000074 | 0.35 | Lipids | Hepatocyte | 1,723 | 3 | 8 | 19 | |
| 1264 | CD27/CD79B ratio | PRORT000411 | 0.35 | Protein ratios | B / plasma cell | 12 | 3 | 15 | 22 | |
| 1265 | TPPP3 levels | PROLV002098 | 0.35 | Protein levels | Muscle / cardiac | 4 | 2 | 4 | 8 | |
| 1266 | ZNF830 levels | PROLV002212 | 0.35 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 1267 | OSM/TGFA ratio | PRORT001617 | 0.35 | Protein ratios | Myeloid | 11 | 2 | 11 | 22 | |
| 1268 | Shift work | SOCIO000008 | 0.35 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 1269 | Diverticular disease | GASTR000011 | 0.34 | Gastrointestinal | Stromal / connective | 95 | 3 | 6 | 17 | |
| 1270 | Iron metabolism disorder | METBL000019 | 0.34 | Metabolic | Myeloid | 59 | 1 | 5 | 24 | |
| 1271 | FKBP4/FKBP5 ratio | PRORT001153 | 0.34 | Protein ratios | Hepatocyte | 13 | 5 | 10 | 21 | |
| 1272 | KL levels | PROLV001147 | 0.34 | Protein levels | Neural / glial | 1 | 1 | 3 | 12 | |
| 1273 | ICAM1/SELE ratio | PRORT001323 | 0.34 | Protein ratios | Granulosa cell | 2 | 1 | 9 | 17 | |
| 1274 | VAT1 levels | PROLV002153 | 0.34 | Protein levels | Myeloid | 51 | 2 | 10 | 19 | |
| 1275 | HSBP1 levels | PROLV000992 | 0.34 | Protein levels | Muscle / cardiac | 19 | 7 | 10 | 27 | |
| 1276 | SERPINA7 levels | PROLV001821 | 0.33 | Protein levels | Hepatocyte | 6 | 3 | 13 | 17 | |
| 1277 | IFI30 levels | PROLV001014 | 0.33 | Protein levels | Myeloid | 93 | 4 | 19 | 45 | |
| 1278 | PRKAB1 levels | PROLV001630 | 0.33 | Protein levels | Lymphocyte | 16 | 3 | 12 | 25 | |
| 1279 | Venous thromboembolism, VTE | VASCU000066 | 0.33 | Vascular | Hepatocyte | 189 | 1 | 5 | 11 | |
| 1280 | FAM177A1 levels | PROLV000764 | 0.33 | Protein levels | Gastrointestinal epithelium | 10 | 1 | 7 | 14 | |
| 1281 | SNAP25 levels | PROLV001906 | 0.33 | Protein levels | Muscle / cardiac | 18 | 1 | 5 | 11 | |
| 1282 | Cholesteryl esters, VLDL | LIPID000018 | 0.33 | Lipids | Hepatocyte | 1,427 | 2 | 8 | 17 | |
| 1283 | Organic acids | METAB000068 | 0.33 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 1284 | Thrombophlebitis | VASCU000063 | 0.33 | Vascular | Hepatocyte | 61 | 1 | 4 | 9 | |
| 1285 | GZMB/IL15 ratio | PRORT001263 | 0.33 | Protein ratios | Lymphocyte | 36 | 2 | 13 | 20 | |
| 1286 | DCTN6/TDRKH ratio | PRORT000875 | 0.33 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 31 | |
| 1287 | CD46 levels | PROLV000342 | 0.33 | Protein levels | Vascular | 58 | 2 | 8 | 12 | |
| 1288 | Respiratory insufficiency | RESPI000031 | 0.32 | Respiratory | Hepatocyte | 0 | 4 | 10 | 29 | |
| 1289 | CCL28/PDGFB ratio | PRORT000354 | 0.32 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 6 | 27 | |
| 1290 | BGLAP levels | PROLV000193 | 0.32 | Protein levels | Stromal / connective | 19 | 3 | 7 | 17 | |
| 1291 | SULT1A1 levels | PROLV001973 | 0.32 | Protein levels | Muscle / cardiac | 31 | 4 | 8 | 23 | |
| 1292 | AHSP levels | PROLV000066 | 0.32 | Protein levels | Muscle / cardiac | 0 | 1 | 4 | 13 | |
| 1293 | EGF/GP6 ratio | PRORT000994 | 0.32 | Protein ratios | Myeloid | 9 | 2 | 6 | 10 | |
| 1294 | Plasma protein metabolism disorder | METBL000029 | 0.32 | Metabolic | Hepatocyte | 26 | 2 | 6 | 24 | |
| 1295 | FOXO3/SH2B3 ratio | PRORT001179 | 0.32 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 21 | |
| 1296 | Liver enzyme levels, GGT | HPBIL000015 | 0.32 | Hepatopancreatobiliary | Hepatocyte | 1,720 | 1 | 7 | 10 | |
| 1297 | NT5C1A levels | PROLV001439 | 0.32 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 1298 | HS6ST1/MEGF9 ratio | PRORT001301 | 0.32 | Protein ratios | Hepatocyte | 86 | 2 | 6 | 7 | |
| 1299 | Pulmonary heart disease | CARDI000027 | 0.32 | Cardiac | Hepatocyte | 56 | 3 | 8 | 16 | |
| 1300 | Hereditary haemolytic anaemia | HEMAT000010 | 0.31 | Hematologic | B / plasma cell | 0 | 1 | 7 | 5 | |
| 1301 | ANXA3/SERPINB1 ratio | PRORT000108 | 0.31 | Protein ratios | Myeloid | 19 | 3 | 9 | 9 | |
| 1302 | FADD/PTPN6 ratio | PRORT001110 | 0.31 | Protein ratios | Hematopoietic progenitor | 0 | 0 | 1 | 3 | |
| 1303 | Hair and follicular disorder | DERMA000030 | 0.31 | Dermatologic | Myeloid | 0 | 0 | 2 | 14 | |
| 1304 | CIAPIN1/SPARC ratio | PRORT000618 | 0.31 | Protein ratios | Myeloid | 9 | 1 | 8 | 13 | |
| 1305 | Oral health conditions, none | DENTA000009 | 0.31 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 1306 | Urinary albumin | NEPHR000020 | 0.31 | Nephrourologic | Vascular | 29 | 2 | 10 | 12 | |
| 1307 | FOLH1 levels | PROLV000821 | 0.31 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 1308 | HS6ST2 levels | PROLV000991 | 0.31 | Protein levels | Muscle / cardiac | 28 | 3 | 7 | 15 | |
| 1309 | YAP1 levels | PROLV002202 | 0.30 | Protein levels | Granulosa cell | 3 | 0 | 5 | 20 | |
| 1310 | Cholines, total | METAB000040 | 0.30 | Metabolites | Hepatocyte | 551 | 3 | 9 | 16 | |
| 1311 | Pneumonopathy | RESPI000016 | 0.30 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 1312 | Tyrosine | METAB000031 | 0.30 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 1313 | YTHDF3 levels | PROLV002207 | 0.30 | Protein levels | Myeloid | 27 | 1 | 6 | 6 | |
| 1314 | ATOX1 levels | PROLV000160 | 0.30 | Protein levels | Myeloid | 25 | 5 | 9 | 20 | |
| 1315 | Gut microbial abundance, Chromatiales | GASTR000024 | 0.30 | Gastrointestinal | Lymphocyte | 0 | 2 | 9 | 20 | |
| 1316 | TIGIT levels | PROLV002034 | 0.30 | Protein levels | Lymphocyte | 28 | 2 | 15 | 23 | |
| 1317 | CXCL12/TIMP3 ratio | PRORT000821 | 0.30 | Protein ratios | Vascular | 21 | 2 | 6 | 10 | |
| 1318 | ENDOU levels | PROLV000703 | 0.30 | Protein levels | Cutaneous epithelium | 77 | 2 | 12 | 12 | |
| 1319 | Heme malignancy, Lymphoma | MALIG000044 | 0.30 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 1320 | IFNGR1/IL10RB ratio | PRORT001331 | 0.30 | Protein ratios | Neural / glial | 4 | 2 | 5 | 11 | |
| 1321 | ACTA2 levels | PROLV000017 | 0.30 | Protein levels | Myeloid | 1 | 1 | 4 | 7 | |
| 1322 | DAG1 levels | PROLV000592 | 0.30 | Protein levels | Lymphocyte | 4 | 4 | 10 | 23 | |
| 1323 | Knee derangements | MSKEL000016 | 0.29 | Musculoskeletal | Stromal / connective | 5 | 1 | 2 | 7 | |
| 1324 | APOB levels | PROLV000120 | 0.29 | Protein levels | Hepatocyte | 618 | 1 | 7 | 9 | |
| 1325 | CNTN3 levels | PROLV000477 | 0.29 | Protein levels | Hepatocyte | 99 | 4 | 9 | 30 | |
| 1326 | F2R/SEMA4D ratio | PRORT001080 | 0.29 | Protein ratios | Muscle / cardiac | 0 | 4 | 10 | 15 | |
| 1327 | Cardiac pacemaker | CARDI000049 | 0.29 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 1328 | JPT2 levels | PROLV001127 | 0.29 | Protein levels | Lymphocyte | 2 | 4 | 10 | 20 | |
| 1329 | Heart rate, exercise | CARDI000017 | 0.29 | Cardiac | Muscle / cardiac | 19 | 6 | 12 | 25 | |
| 1330 | Triglycerides, HDL | LIPID000033 | 0.29 | Lipids | Hepatocyte | 1,558 | 3 | 8 | 16 | |
| 1331 | CD38 levels | PROLV000338 | 0.29 | Protein levels | Muscle / cardiac | 53 | 1 | 5 | 6 | |
| 1332 | Polyglandular dysfunction | IMMUN000037 | 0.29 | Immunologic | B / plasma cell | 0 | 3 | 10 | 21 | |
| 1333 | LAMP2 levels | PROLV001181 | 0.29 | Protein levels | Myeloid | 51 | 1 | 8 | 7 | |
| 1334 | Patellar disorder | MSKEL000018 | 0.28 | Musculoskeletal | Neural / glial | 0 | 0 | 4 | 8 | |
| 1335 | NQO2 levels | PROLV001430 | 0.28 | Protein levels | Muscle / cardiac | 22 | 1 | 6 | 13 | |
| 1336 | HS1BP3 levels | PROLV000989 | 0.28 | Protein levels | Stromal / connective | 24 | 6 | 12 | 24 | |
| 1337 | Hypokalaemia | METBL000006 | 0.28 | Metabolic | Hepatocyte | 0 | 1 | 4 | 15 | |
| 1338 | Arm mass | BCOMP000014 | 0.28 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 1339 | Branched-chain amino acid metabolites | METAB000004 | 0.28 | Metabolites | Lymphocyte | 0 | 1 | 8 | 31 | |
| 1340 | Phospholipids, VLDL | LIPID000051 | 0.28 | Lipids | Hepatocyte | 1,563 | 2 | 8 | 19 | |
| 1341 | METAP1D levels | PROLV001303 | 0.28 | Protein levels | Myeloid | 4 | 4 | 7 | 16 | |
| 1342 | Phenylalanine | METAB000027 | 0.28 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 1343 | Myo-inositol | METAB000036 | 0.28 | Metabolites | Lymphocyte | 0 | 1 | 10 | 27 | |
| 1344 | BOLA2 or BOLA2B levels | PROLV000208 | 0.28 | Protein levels | Lymphocyte | 3 | 2 | 7 | 24 | |
| 1345 | Cholesterol, total | LIPID000014 | 0.28 | Lipids | Hepatocyte | 1,261 | 1 | 6 | 10 | |
| 1346 | SCLY/SORD ratio | PRORT001764 | 0.28 | Protein ratios | Myeloid | 1 | 3 | 10 | 16 | |
| 1347 | Osteoporosis | MSKEL000010 | 0.28 | Musculoskeletal | Stromal / connective | 5 | 3 | 5 | 21 | |
| 1348 | Chronic viral hepatitis | IMMUN000056 | 0.28 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 1349 | CPB1/KIRREL2 ratio | PRORT000726 | 0.28 | Protein ratios | Pancreatic epithelium | 30 | 0 | 3 | 5 | |
| 1350 | PDGFA/SPARC ratio | PRORT001637 | 0.27 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 1351 | SH2B3/SUGT1 ratio | PRORT001783 | 0.27 | Protein ratios | Muscle / cardiac | 24 | 3 | 9 | 23 | |
| 1352 | Basal metabolic rate | METBL000007 | 0.27 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 1353 | EGFLAM levels | PROLV000686 | 0.27 | Protein levels | Hepatocyte | 53 | 2 | 10 | 16 | |
| 1354 | CLEC1B/PPP1R2 ratio | PRORT000647 | 0.27 | Protein ratios | Myeloid | 7 | 3 | 7 | 18 | |
| 1355 | TIMP3/ZBTB16 ratio | PRORT001838 | 0.27 | Protein ratios | Vascular | 1 | 2 | 7 | 20 | |
| 1356 | CXCL16 levels | PROLV000581 | 0.27 | Protein levels | Lymphocyte | 67 | 3 | 13 | 36 | |
| 1357 | Cholesterol, VLDL | LIPID000009 | 0.27 | Lipids | Hepatocyte | 1,391 | 2 | 9 | 14 | |
| 1358 | CLEC1B/DAB2 ratio | PRORT000633 | 0.27 | Protein ratios | Lymphocyte | 9 | 4 | 15 | 43 | |
| 1359 | TSPAN1 levels | PROLV002115 | 0.27 | Protein levels | Myeloid | 19 | 1 | 8 | 10 | |
| 1360 | STC1 levels | PROLV001960 | 0.27 | Protein levels | Vascular | 2 | 1 | 6 | 12 | |
| 1361 | ITGA6 levels | PROLV001107 | 0.27 | Protein levels | Myeloid | 24 | 2 | 6 | 15 | |
| 1362 | Stevens-Johnson syndrome, SJS | IMMUN000001 | 0.27 | Immunologic | Lymphocyte | 3 | 2 | 10 | 28 | |
| 1363 | AMBP/EFEMP1 ratio | PRORT000085 | 0.27 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 11 | |
| 1364 | Phosphatidylethanolamines | LIPID000059 | 0.27 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 1365 | CEP43/MPHOSPH8 ratio | PRORT000599 | 0.27 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 1366 | NPTX2 levels | PROLV001427 | 0.27 | Protein levels | Myeloid | 12 | 3 | 10 | 16 | |
| 1367 | Fatty acids, monounsaturated | LIPID000023 | 0.26 | Lipids | Hepatocyte | 1,143 | 2 | 10 | 17 | |
| 1368 | CALCOCO1/CASP8 ratio | PRORT000292 | 0.26 | Protein ratios | Muscle / cardiac | 14 | 3 | 8 | 19 | |
| 1369 | Medication, coronary artery disease | VASCU000037 | 0.26 | Vascular | Vascular | 121 | 5 | 8 | 17 | |
| 1370 | RBM17 levels | PROLV001710 | 0.26 | Protein levels | Vascular | 9 | 0 | 3 | 10 | |
| 1371 | Respiratory disease | RESPI000004 | 0.26 | Respiratory | Lymphocyte | 194 | 2 | 11 | 11 | |
| 1372 | CD84/SORT1 ratio | PRORT000528 | 0.26 | Protein ratios | Myeloid | 44 | 2 | 10 | 15 | |
| 1373 | HMBS/PSMG3 ratio | PRORT001289 | 0.26 | Protein ratios | Hepatocyte | 15 | 4 | 10 | 29 | |
| 1374 | CPB1 levels | PROLV000504 | 0.26 | Protein levels | Pancreatic epithelium | 91 | 0 | 5 | 3 | |
| 1375 | Retinal morphology | OPHTH000041 | 0.26 | Ophthalmic | Melanocyte | 0 | 1 | 4 | 5 | |
| 1376 | PLA2G15/PRCP ratio | PRORT001670 | 0.26 | Protein ratios | Myeloid | 44 | 3 | 11 | 21 | |
| 1377 | Chronic kidney disease | NEPHR000001 | 0.26 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 1378 | GGT5 levels | PROLV000884 | 0.26 | Protein levels | Hepatocyte | 21 | 1 | 8 | 12 | |
| 1379 | DNM1 levels | PROLV000638 | 0.26 | Protein levels | Stromal / connective | 7 | 1 | 3 | 11 | |
| 1380 | IBD-Inflammatory bowel disease | IMMUN000030 | 0.25 | Immunologic | Lymphocyte | 230 | 4 | 19 | 29 | |
| 1381 | CKAP4/LTBR ratio | PRORT000622 | 0.25 | Protein ratios | Muscle / cardiac | 17 | 1 | 6 | 18 | |
| 1382 | SORT1/VSIR ratio | PRORT001804 | 0.25 | Protein ratios | Myeloid | 28 | 3 | 8 | 13 | |
| 1383 | CHMP6 levels | PROLV000432 | 0.25 | Protein levels | Stromal / connective | 7 | 4 | 6 | 19 | |
| 1384 | Cutaneous fungal infection | IMMUN000058 | 0.25 | Immunologic | Myeloid | 28 | 1 | 9 | 13 | |
| 1385 | Blood pressure, BP, diastolic | VASCU000009 | 0.25 | Vascular | Vascular | 1,488 | 3 | 6 | 10 | |
| 1386 | TCN2 levels | PROLV002004 | 0.25 | Protein levels | Myeloid | 63 | 2 | 8 | 12 | |
| 1387 | Peripheral vascular disease | VASCU000043 | 0.25 | Vascular | Stromal / connective | 65 | 3 | 6 | 14 | |
| 1388 | DPEP1 levels | PROLV000643 | 0.25 | Protein levels | Myeloid | 74 | 2 | 6 | 16 | |
| 1389 | RUVBL1 levels | PROLV001764 | 0.25 | Protein levels | B / plasma cell | 8 | 1 | 5 | 6 | |
| 1390 | ATP5IF1/HSPA1A ratio | PRORT000158 | 0.24 | Protein ratios | Myeloid | 21 | 3 | 7 | 15 | |
| 1391 | CD48/CRTAM ratio | PRORT000463 | 0.24 | Protein ratios | Lymphocyte | 45 | 2 | 15 | 25 | |
| 1392 | CPM/PCSK9 ratio | PRORT000731 | 0.24 | Protein ratios | Hepatocyte | 71 | 2 | 8 | 13 | |
| 1393 | Bile acid levels | HPBIL000016 | 0.24 | Hepatopancreatobiliary | Hepatocyte | 12 | 1 | 5 | 10 | |
| 1394 | EBAG9/FKBP5 ratio | PRORT000958 | 0.24 | Protein ratios | Lymphocyte | 1 | 5 | 8 | 24 | |
| 1395 | Cholesteryl esters, LDL | LIPID000017 | 0.24 | Lipids | Hepatocyte | 834 | 1 | 8 | 13 | |
| 1396 | DKK1/IPCEF1 ratio | PRORT000895 | 0.24 | Protein ratios | Lymphocyte | 2 | 3 | 14 | 36 | |
| 1397 | CD300LG/CD93 ratio | PRORT000433 | 0.24 | Protein ratios | Vascular | 3 | 2 | 5 | 16 | |
| 1398 | Ganglion cyst | MSKEL000065 | 0.24 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 1399 | Medication, post-myocardial infarction | CARDI000045 | 0.24 | Cardiac | Vascular | 76 | 4 | 9 | 11 | |
| 1400 | AKT2 levels | PROLV000075 | 0.24 | Protein levels | Stromal / connective | 6 | 3 | 10 | 21 | |
| 1401 | CRADD/STAMBP ratio | PRORT000750 | 0.24 | Protein ratios | Myeloid | 0 | 3 | 10 | 17 | |
| 1402 | Spondylopathy | MSKEL000080 | 0.24 | Musculoskeletal | Stromal / connective | 21 | 2 | 2 | 10 | |
| 1403 | PDGFB/ST6GAL1 ratio | PRORT001647 | 0.24 | Protein ratios | Neural / glial | 12 | 6 | 11 | 24 | |
| 1404 | EBAG9/TBCB ratio | PRORT000961 | 0.24 | Protein ratios | Myeloid | 0 | 2 | 7 | 16 | |
| 1405 | DUSP29 levels | PROLV000662 | 0.24 | Protein levels | Muscle / cardiac | 2 | 2 | 5 | 8 | |
| 1406 | OXCT1 levels | PROLV001479 | 0.24 | Protein levels | Myeloid | 26 | 3 | 10 | 10 | |
| 1407 | CRELD2/HYOU1 ratio | PRORT000756 | 0.24 | Protein ratios | Granulosa cell | 19 | 1 | 6 | 2 | |
| 1408 | CIAPIN1/VEGFC ratio | PRORT000619 | 0.24 | Protein ratios | Platelet | 3 | 2 | 9 | 30 | |
| 1409 | USP8/WASF1 ratio | PRORT001858 | 0.23 | Protein ratios | Myeloid | 1 | 3 | 8 | 12 | |
| 1410 | ITM2A levels | PROLV001120 | 0.23 | Protein levels | Hepatocyte | 32 | 3 | 11 | 28 | |
| 1411 | CLEC1A levels | PROLV000447 | 0.23 | Protein levels | Myeloid | 10 | 0 | 5 | 9 | |
| 1412 | HEXIM1/NT5C3A ratio | PRORT001278 | 0.23 | Protein ratios | Hepatocyte | 17 | 4 | 10 | 20 | |
| 1413 | THY1/TNFRSF21 ratio | PRORT001836 | 0.23 | Protein ratios | Lymphocyte | 1 | 1 | 4 | 6 | |
| 1414 | Benign neoplasm, Endocrine | MALIG000003 | 0.23 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 1415 | ALDH1A1/CA2 ratio | PRORT000077 | 0.23 | Protein ratios | Hepatocyte | 9 | 1 | 4 | 17 | |
| 1416 | PEPD levels | PROLV001536 | 0.23 | Protein levels | Myeloid | 66 | 2 | 7 | 7 | |
| 1417 | HSPA1A levels | PROLV000996 | 0.23 | Protein levels | Lymphocyte | 33 | 3 | 14 | 40 | |
| 1418 | Diabetes, with complication | METBL000035 | 0.23 | Metabolic | Neural / glial | 74 | 1 | 4 | 9 | |
| 1419 | HbA1c | METBL000039 | 0.23 | Metabolic | Hematopoietic progenitor | 970 | 0 | 3 | 10 | |
| 1420 | FKBP1B/PRDX5 ratio | PRORT001151 | 0.23 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 31 | |
| 1421 | ADH1B levels | PROLV000048 | 0.23 | Protein levels | Hepatocyte | 54 | 2 | 9 | 11 | |
| 1422 | CD244/CRTAM ratio | PRORT000406 | 0.23 | Protein ratios | Lymphocyte | 30 | 2 | 14 | 25 | |
| 1423 | Medication, lipid-lowering | METBL000028 | 0.23 | Metabolic | Hepatocyte | 589 | 1 | 7 | 4 | |
| 1424 | ANXA3/BID ratio | PRORT000104 | 0.23 | Protein ratios | Hepatocyte | 22 | 1 | 5 | 7 | |
| 1425 | VSIR levels | PROLV002172 | 0.22 | Protein levels | Myeloid | 41 | 3 | 7 | 11 | |
| 1426 | BSG/LAMP3 ratio | PRORT000248 | 0.22 | Protein ratios | Myeloid | 33 | 1 | 8 | 14 | |
| 1427 | Granulocyte | HEMAT000031 | 0.22 | Hematologic | Myeloid | 770 | 2 | 8 | 12 | |
| 1428 | RNASE1 levels | PROLV001737 | 0.22 | Protein levels | Myeloid | 7 | 3 | 5 | 9 | |
| 1429 | CEP43/WASF1 ratio | PRORT000603 | 0.22 | Protein ratios | Myeloid | 0 | 1 | 7 | 11 | |
| 1430 | TSPAN8 levels | PROLV002116 | 0.22 | Protein levels | Hepatocyte | 56 | 1 | 9 | 15 | |
| 1431 | Aortic aneurysm | VASCU000002 | 0.22 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 1432 | F2R/SERPINE1 ratio | PRORT001081 | 0.22 | Protein ratios | Myeloid | 15 | 3 | 12 | 20 | |
| 1433 | Coronary artery disease, CAD | VASCU000020 | 0.22 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 1434 | ROBO2 levels | PROLV001750 | 0.22 | Protein levels | Adipose | 69 | 5 | 10 | 24 | |
| 1435 | BID levels | PROLV000195 | 0.22 | Protein levels | Myeloid | 15 | 3 | 7 | 16 | |
| 1436 | Ketone bodies | METAB000056 | 0.22 | Metabolites | Hepatocyte | 118 | 1 | 6 | 7 | |
| 1437 | MUC16 levels | PROLV001352 | 0.22 | Protein levels | Vascular | 0 | 0 | 4 | 3 | |
| 1438 | CXCL11/ITGB1BP2 ratio | PRORT000818 | 0.22 | Protein ratios | Muscle / cardiac | 1 | 3 | 8 | 15 | |
| 1439 | CEACAM8 levels | PROLV000394 | 0.22 | Protein levels | Myeloid | 75 | 2 | 11 | 14 | |
| 1440 | Cancer, Cervix | MALIG000012 | 0.22 | Malignancy | Lymphocyte | 23 | 0 | 4 | 30 | |
| 1441 | COX5B/GFER ratio | PRORT000716 | 0.22 | Protein ratios | Lymphocyte | 1 | 1 | 12 | 33 | |
| 1442 | Heart failure, chronic | CARDI000003 | 0.22 | Cardiac | Muscle / cardiac | 0 | 3 | 7 | 16 | |
| 1443 | CRADD/FKBP4 ratio | PRORT000746 | 0.22 | Protein ratios | Hepatocyte | 7 | 2 | 7 | 14 | |
| 1444 | Plant sterols | METAB000074 | 0.22 | Metabolites | Hepatocyte | 6 | 2 | 4 | 14 | |
| 1445 | EREG/ITGB1BP2 ratio | PRORT001056 | 0.21 | Protein ratios | Myeloid | 12 | 4 | 8 | 19 | |
| 1446 | TFF2 levels | PROLV002013 | 0.21 | Protein levels | Pancreatic epithelium | 17 | 1 | 2 | 5 | |
| 1447 | CRADD/SIRT2 ratio | PRORT000749 | 0.21 | Protein ratios | Hepatocyte | 16 | 1 | 9 | 19 | |
| 1448 | Dorsopathy | MSKEL000075 | 0.21 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 1449 | Hypertensive heart disease | CARDI000038 | 0.21 | Cardiac | Vascular | 23 | 0 | 1 | 8 | |
| 1450 | Triglycerides, VLDL | LIPID000036 | 0.21 | Lipids | Hepatocyte | 1,580 | 3 | 8 | 16 | |
| 1451 | CDKN1A/ENO2 ratio | PRORT000566 | 0.21 | Protein ratios | Hepatocyte | 21 | 3 | 8 | 18 | |
| 1452 | Atherosclerosis | VASCU000006 | 0.21 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 1453 | GHRL levels | PROLV000886 | 0.21 | Protein levels | Hepatocyte | 39 | 2 | 6 | 15 | |
| 1454 | Cholesterol, VLDL free | LIPID000008 | 0.21 | Lipids | Hepatocyte | 1,347 | 2 | 8 | 17 | |
| 1455 | KLB levels | PROLV001148 | 0.21 | Protein levels | Hepatocyte | 138 | 1 | 9 | 23 | |
| 1456 | FABP1 levels | PROLV000751 | 0.21 | Protein levels | Neural / glial | 0 | 2 | 9 | 16 | |
| 1457 | Carnitine | METAB000039 | 0.21 | Metabolites | Myeloid | 32 | 1 | 4 | 7 | |
| 1458 | Microscopic colitis | IMMUN000033 | 0.20 | Immunologic | Muscle / cardiac | 7 | 1 | 4 | 12 | |
| 1459 | CCL26 levels | PROLV000293 | 0.20 | Protein levels | Lymphocyte | 64 | 3 | 8 | 16 | |
| 1460 | GRSF1 levels | PROLV000936 | 0.20 | Protein levels | Myeloid | 3 | 3 | 9 | 10 | |
| 1461 | KLK14 levels | PROLV001154 | 0.20 | Protein levels | Neural / glial | 28 | 1 | 10 | 8 | |
| 1462 | Body fat percentage, sex interaction | BCOMP000002 | 0.20 | Body composition | Muscle / cardiac | 0 | 2 | 6 | 13 | |
| 1463 | PLXNA4/SUSD1 ratio | PRORT001687 | 0.20 | Protein ratios | Lymphocyte | 1 | 2 | 7 | 26 | |
| 1464 | HGFAC levels | PROLV000966 | 0.20 | Protein levels | Hepatocyte | 160 | 3 | 10 | 16 | |
| 1465 | EDAR/SERPINB1 ratio | PRORT000977 | 0.20 | Protein ratios | Myeloid | 29 | 2 | 8 | 14 | |
| 1466 | PPL levels | PROLV001609 | 0.20 | Protein levels | Lymphocyte | 0 | 0 | 2 | 6 | |
| 1467 | APP/NID2 ratio | PRORT000129 | 0.20 | Protein ratios | Stromal / connective | 0 | 2 | 6 | 11 | |
| 1468 | Joint replacement | MSKEL000049 | 0.20 | Musculoskeletal | Hepatocyte | 7 | 1 | 5 | 6 | |
| 1469 | SNAP29/TJAP1 ratio | PRORT001799 | 0.20 | Protein ratios | Myeloid | 27 | 5 | 14 | 22 | |
| 1470 | Fracture | MSKEL000011 | 0.20 | Musculoskeletal | Stromal / connective | 27 | 1 | 1 | 1 | |
| 1471 | PLAT levels | PROLV001571 | 0.20 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 1472 | OPLAH levels | PROLV001471 | 0.20 | Protein levels | Lymphocyte | 8 | 0 | 7 | 13 | |
| 1473 | LZTFL1 levels | PROLV001256 | 0.20 | Protein levels | Myeloid | 5 | 3 | 6 | 14 | |
| 1474 | SNX9 levels | PROLV001915 | 0.20 | Protein levels | Vascular | 12 | 1 | 4 | 20 | |
| 1475 | CD99L2 levels | PROLV000364 | 0.19 | Protein levels | Hepatocyte | 88 | 1 | 7 | 18 | |
| 1476 | PHYKPL levels | PROLV001552 | 0.19 | Protein levels | Lymphocyte | 3 | 2 | 6 | 16 | |
| 1477 | CD40/TIMP3 ratio | PRORT000446 | 0.19 | Protein ratios | Vascular | 9 | 1 | 4 | 7 | |
| 1478 | ATXN10 levels | PROLV000164 | 0.19 | Protein levels | Vascular | 7 | 3 | 9 | 20 | |
| 1479 | Arterial disease | VASCU000023 | 0.19 | Vascular | Vascular | 66 | 3 | 10 | 16 | |
| 1480 | PSIP1 levels | PROLV001657 | 0.19 | Protein levels | Muscle / cardiac | 10 | 2 | 10 | 35 | |
| 1481 | Consultant specialty, ophthalmology | MISCL000018 | 0.19 | Miscellaneous | Vascular | 0 | 4 | 12 | 22 | |
| 1482 | ARF6 levels | PROLV000133 | 0.19 | Protein levels | Stromal / connective | 50 | 5 | 15 | 21 | |
| 1483 | LTA4H levels | PROLV001240 | 0.19 | Protein levels | Muscle / cardiac | 0 | 3 | 16 | 38 | |
| 1484 | NECTIN2/NPDC1 ratio | PRORT001577 | 0.19 | Protein ratios | Vascular | 16 | 2 | 13 | 18 | |
| 1485 | Lipoprotein particles | LIPID000047 | 0.19 | Lipids | Hepatocyte | 781 | 3 | 9 | 18 | |
| 1486 | TDRKH/TST ratio | PRORT001830 | 0.19 | Protein ratios | Myeloid | 11 | 6 | 16 | 28 | |
| 1487 | Aortic diameter | VASCU000052 | 0.19 | Vascular | Muscle / cardiac | 215 | 5 | 7 | 19 | |
| 1488 | APBB1IP levels | PROLV000112 | 0.19 | Protein levels | Myeloid | 38 | 4 | 17 | 27 | |
| 1489 | Valvular heart disease | CARDI000054 | 0.19 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 1490 | Nasal polyp | RESPI000037 | 0.19 | Respiratory | Lymphocyte | 11 | 2 | 11 | 20 | |
| 1491 | FADD/GRAP2 ratio | PRORT001103 | 0.18 | Protein ratios | Neural / glial | 1 | 3 | 6 | 9 | |
| 1492 | UPB1 levels | PROLV002142 | 0.18 | Protein levels | Hepatocyte | 31 | 1 | 5 | 11 | |
| 1493 | ART3/RGMB ratio | PRORT000146 | 0.18 | Protein ratios | Myeloid | 11 | 3 | 8 | 23 | |
| 1494 | FAM171B levels | PROLV000761 | 0.18 | Protein levels | Muscle / cardiac | 12 | 2 | 4 | 8 | |
| 1495 | Food-related dermatitis | DERMA000011 | 0.18 | Dermatologic | Lymphocyte | 0 | 0 | 9 | 19 | |
| 1496 | Fatty acids, saturated | LIPID000027 | 0.18 | Lipids | Hepatocyte | 696 | 1 | 7 | 12 | |
| 1497 | IL18BP/ROR1 ratio | PRORT001346 | 0.18 | Protein ratios | Myeloid | 6 | 3 | 14 | 30 | |
| 1498 | REG4 levels | PROLV001720 | 0.18 | Protein levels | Pancreatic epithelium | 61 | 0 | 6 | 9 | |
| 1499 | CLMP/TNFRSF19 ratio | PRORT000671 | 0.18 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 1500 | PRL levels | PROLV001635 | 0.18 | Protein levels | Lymphocyte | 17 | 2 | 9 | 27 | |
| 1501 | TRIM40 levels | PROLV002109 | 0.18 | Protein levels | Muscle / cardiac | 52 | 4 | 10 | 9 | |
| 1502 | NUDT5/RWDD1 ratio | PRORT001609 | 0.18 | Protein ratios | Myeloid | 10 | 6 | 14 | 32 | |
| 1503 | TNFRSF11B/TNFSF11 ratio | PRORT001845 | 0.18 | Protein ratios | Hepatocyte | 18 | 1 | 9 | 11 | |
| 1504 | FURIN levels | PROLV000835 | 0.18 | Protein levels | Myeloid | 29 | 3 | 8 | 13 | |
| 1505 | Sinusitis | RESPI000039 | 0.18 | Respiratory | Lymphocyte | 11 | 2 | 13 | 30 | |
| 1506 | DKK3/LTBP2 ratio | PRORT000908 | 0.18 | Protein ratios | Neural / glial | 1 | 1 | 5 | 13 | |
| 1507 | Creatine metabolites | METAB000058 | 0.18 | Metabolites | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 1508 | Phospholipids, lipoprotein particles | LIPID000052 | 0.18 | Lipids | Hepatocyte | 430 | 2 | 9 | 15 | |
| 1509 | Ventricular mass-to-volume ratio | CARDI000013 | 0.18 | Cardiac | Muscle / cardiac | 40 | 3 | 5 | 17 | |
| 1510 | AXIN1/CDKN1A ratio | PRORT000166 | 0.18 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 1511 | LAT/MANF ratio | PRORT001423 | 0.18 | Protein ratios | Muscle / cardiac | 0 | 3 | 6 | 14 | |
| 1512 | CDC37/PPP1R12A ratio | PRORT000540 | 0.18 | Protein ratios | Muscle / cardiac | 1 | 3 | 10 | 19 | |
| 1513 | CDH1/CST3 ratio | PRORT000546 | 0.18 | Protein ratios | Hepatocyte | 11 | 1 | 7 | 16 | |
| 1514 | Pain, widespread | MSKEL000042 | 0.18 | Musculoskeletal | Lymphocyte | 0 | 2 | 16 | 37 | |
| 1515 | COMP/ITGAV ratio | PRORT000711 | 0.18 | Protein ratios | Myeloid | 58 | 3 | 11 | 18 | |
| 1516 | DPP6/NELL2 ratio | PRORT000945 | 0.18 | Protein ratios | Myeloid | 5 | 2 | 8 | 15 | |
| 1517 | Hypothyroidism, postinfectious | ENDOC000014 | 0.18 | Endocrine | Myeloid | — | 1 | 6 | 11 | |
| 1518 | Bone infection | IMMUN000053 | 0.18 | Immunologic | Myeloid | 0 | 3 | 10 | 24 | |
| 1519 | Bleeding gums | DENTA000011 | 0.18 | Dental | Lymphocyte | 0 | 0 | 12 | 15 | |
| 1520 | Tyrosine metabolites | METAB000016 | 0.18 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 1521 | Sacroiliitis | MSKEL000020 | 0.18 | Musculoskeletal | Muscle / cardiac | 35 | 4 | 9 | 31 | |
| 1522 | DNMBP/WWP2 ratio | PRORT000934 | 0.17 | Protein ratios | Lymphocyte | 12 | 2 | 12 | 42 | |
| 1523 | ATOX1/SNAP29 ratio | PRORT000151 | 0.17 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 24 | |
| 1524 | Arm impedance | BCOMP000013 | 0.17 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 1525 | Exotropia | OPHTH000022 | 0.17 | Ophthalmic | Myeloid | 6 | 1 | 8 | 7 | |
| 1526 | EIF4G1/PLA2G4A ratio | PRORT001013 | 0.17 | Protein ratios | Vascular | 11 | 2 | 10 | 16 | |
| 1527 | Ventricular wall thickness | CARDI000016 | 0.17 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 1528 | Lipid unsaturation | LIPID000079 | 0.17 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 1529 | RRM2B levels | PROLV001757 | 0.17 | Protein levels | Myeloid | 1 | 3 | 8 | 10 | |
| 1530 | KITLG/PLTP ratio | PRORT001407 | 0.17 | Protein ratios | Hepatocyte | 23 | 1 | 6 | 14 | |
| 1531 | HSPB6/SNCG ratio | PRORT001306 | 0.17 | Protein ratios | Muscle / cardiac | 1 | 2 | 6 | 10 | |
| 1532 | MAN1A2 levels | PROLV001260 | 0.17 | Protein levels | Myeloid | 160 | 3 | 12 | 14 | |
| 1533 | ITPR1 levels | PROLV001122 | 0.17 | Protein levels | Vascular | 20 | 3 | 13 | 25 | |
| 1534 | PGA4 levels | PROLV001542 | 0.17 | Protein levels | Pancreatic epithelium | 31 | 0 | 7 | 8 | |
| 1535 | Estradiol | ENDOC000006 | 0.17 | Endocrine | Hepatocyte | 16 | 3 | 9 | 17 | |
| 1536 | Alzheimer disease | NEURO000018 | 0.17 | Neurologic | Myeloid | 182 | 2 | 8 | 9 | |
| 1537 | KDM3A levels | PROLV001132 | 0.17 | Protein levels | Lymphocyte | 21 | 2 | 16 | 40 | |
| 1538 | SNAP23/SNAP29 ratio | PRORT001793 | 0.17 | Protein ratios | Lymphocyte | 0 | 3 | 7 | 15 | |
| 1539 | CELA3A levels | PROLV000397 | 0.17 | Protein levels | Pancreatic epithelium | 72 | 0 | 3 | 1 | |
| 1540 | DKK1 levels | PROLV000620 | 0.17 | Protein levels | Myeloid | 37 | 2 | 9 | 12 | |
| 1541 | Cancer, Kidney | MALIG000016 | 0.17 | Malignancy | Pancreatic epithelium | 1 | 0 | 6 | 12 | |
| 1542 | CSNK1D levels | PROLV000542 | 0.17 | Protein levels | Lymphocyte | 32 | 2 | 12 | 32 | |
| 1543 | INSL4 levels | PROLV001092 | 0.16 | Protein levels | Muscle / cardiac | 3 | 2 | 4 | 12 | |
| 1544 | MFGE8 levels | PROLV001307 | 0.16 | Protein levels | Myeloid | 168 | 3 | 13 | 26 | |
| 1545 | PLXNA4/USP8 ratio | PRORT001688 | 0.16 | Protein ratios | B / plasma cell | 5 | 4 | 8 | 32 | |
| 1546 | CAMSAP1 levels | PROLV000260 | 0.16 | Protein levels | Myeloid | 2 | 2 | 2 | 10 | |
| 1547 | Waist-hip ratio | BMORP000014 | 0.16 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 1548 | SLC27A4/TDRKH ratio | PRORT001790 | 0.16 | Protein ratios | Stromal / connective | 0 | 1 | 4 | 11 | |
| 1549 | COL4A1 levels | PROLV000490 | 0.16 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 1550 | HSPG2/IGFBP6 ratio | PRORT001307 | 0.16 | Protein ratios | Adipose | 15 | 3 | 9 | 18 | |
| 1551 | CASP3/SNAP23 ratio | PRORT000320 | 0.16 | Protein ratios | Muscle / cardiac | 25 | 4 | 11 | 22 | |
| 1552 | SNX9/VASH1 ratio | PRORT001802 | 0.16 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 1553 | DKK1/PPCDC ratio | PRORT000899 | 0.16 | Protein ratios | Myeloid | 14 | 2 | 10 | 16 | |
| 1554 | BIRC2 levels | PROLV000198 | 0.16 | Protein levels | Stromal / connective | 1 | 3 | 7 | 14 | |
| 1555 | FCER2/FCRL1 ratio | PRORT001120 | 0.16 | Protein ratios | B / plasma cell | 37 | 3 | 9 | 14 | |
| 1556 | MME levels | PROLV001320 | 0.16 | Protein levels | Hepatocyte | 134 | 1 | 5 | 9 | |
| 1557 | CD40LG/EDAR ratio | PRORT000448 | 0.16 | Protein ratios | Myeloid | 8 | 2 | 10 | 16 | |
| 1558 | Fatty acids, stearic acid | LIPID000028 | 0.16 | Lipids | Hepatocyte | 0 | 2 | 5 | 9 | |
| 1559 | Carbohydrate metabolites | METAB000035 | 0.16 | Metabolites | Hepatocyte | 7 | 2 | 13 | 22 | |
| 1560 | CSNK2A1 or CSNK2B levels | PROLV000545 | 0.16 | Protein levels | B / plasma cell | 1 | 0 | 8 | 5 | |
| 1561 | Infective dermatitis | DERMA000012 | 0.16 | Dermatologic | Lymphocyte | 8 | 3 | 14 | 18 | |
| 1562 | Cancer, Lung | MALIG000019 | 0.16 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 1563 | Perivascular space burden | NIMAG000011 | 0.16 | Neuroimaging | Muscle / cardiac | 3 | 2 | 5 | 7 | |
| 1564 | GP2 levels | PROLV000915 | 0.16 | Protein levels | Pancreatic epithelium | 17 | 0 | 4 | 6 | |
| 1565 | MSRA/P4HB ratio | PRORT001561 | 0.15 | Protein ratios | Neural / glial | 24 | 6 | 15 | 25 | |
| 1566 | Medication, respiratory | RESPI000007 | 0.15 | Respiratory | Myeloid | 1 | 2 | 6 | 7 | |
| 1567 | CFH levels | PROLV000413 | 0.15 | Protein levels | Stromal / connective | 20 | 4 | 12 | 18 | |
| 1568 | HSD11B1 levels | PROLV000993 | 0.15 | Protein levels | Hepatocyte | 168 | 1 | 9 | 13 | |
| 1569 | TRIM5 levels | PROLV002110 | 0.15 | Protein levels | Hepatocyte | 9 | 2 | 12 | 30 | |
| 1570 | Cardiac conduction disorder | CARDI000030 | 0.15 | Cardiac | Muscle / cardiac | 14 | 3 | 6 | 13 | |
| 1571 | NPDC1 levels | PROLV001420 | 0.15 | Protein levels | Vascular | 9 | 0 | 8 | 13 | |
| 1572 | TGFBI levels | PROLV002021 | 0.15 | Protein levels | Hepatocyte | 152 | 3 | 10 | 12 | |
| 1573 | CPM/LAMP2 ratio | PRORT000730 | 0.15 | Protein ratios | Hepatocyte | 42 | 2 | 11 | 22 | |
| 1574 | REG1A/REG4 ratio | PRORT001730 | 0.15 | Protein ratios | Hepatocyte | 35 | 1 | 6 | 14 | |
| 1575 | Triglycerides/HDL cholesterol | LIPID000041 | 0.15 | Lipids | Hepatocyte | 792 | 3 | 9 | 19 | |
| 1576 | HBEGF/SDC4 ratio | PRORT001271 | 0.15 | Protein ratios | Myeloid | 56 | 2 | 9 | 18 | |
| 1577 | Isoleucine | METAB000024 | 0.15 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 1578 | CD59 levels | PROLV000347 | 0.15 | Protein levels | Muscle / cardiac | 31 | 3 | 6 | 9 | |
| 1579 | Epigenetic age acceleration | AGING000002 | 0.15 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 1580 | PAMR1/RARRES2 ratio | PRORT001620 | 0.15 | Protein ratios | Hepatocyte | 48 | 2 | 7 | 14 | |
| 1581 | NCAM2 levels | PROLV001378 | 0.15 | Protein levels | Myeloid | 33 | 3 | 7 | 17 | |
| 1582 | Cervicobrachial syndrome | MSKEL000073 | 0.15 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 8 | 15 | |
| 1583 | Alanine metabolite | METAB000001 | 0.15 | Metabolites | Gastrointestinal epithelium | 0 | 2 | 9 | 7 | |
| 1584 | Triglycerides, IDL | LIPID000034 | 0.15 | Lipids | Hepatocyte | 918 | 2 | 9 | 15 | |
| 1585 | NELL1 levels | PROLV001390 | 0.14 | Protein levels | Renal epithelium | 16 | 0 | 8 | 22 | |
| 1586 | IL15RA levels | PROLV001049 | 0.14 | Protein levels | Lymphocyte | 1 | 0 | 7 | 10 | |
| 1587 | PGF levels | PROLV001544 | 0.14 | Protein levels | Vascular | 24 | 1 | 4 | 14 | |
| 1588 | Benign neoplasm, Uterus | MALIG000008 | 0.14 | Malignancy | Lymphocyte | 38 | 0 | 2 | 26 | |
| 1589 | F5 levels | PROLV000747 | 0.14 | Protein levels | Muscle / cardiac | 0 | 3 | 14 | 28 | |
| 1590 | C1QTNF1/COL18A1 ratio | PRORT000262 | 0.14 | Protein ratios | B / plasma cell | 6 | 3 | 8 | 18 | |
| 1591 | Aortic elasticity | VASCU000049 | 0.14 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 1592 | FXYD5 levels | PROLV000841 | 0.14 | Protein levels | Myeloid | 24 | 4 | 11 | 19 | |
| 1593 | FLT4/KDR ratio | PRORT001167 | 0.14 | Protein ratios | Vascular | 28 | 1 | 7 | 21 | |
| 1594 | PRAP1 levels | PROLV001623 | 0.14 | Protein levels | Hematopoietic progenitor | 16 | 2 | 6 | 11 | |
| 1595 | RNASE3 levels | PROLV001738 | 0.14 | Protein levels | Myeloid | 39 | 4 | 15 | 28 | |
| 1596 | CELA3A/KIRREL2 ratio | PRORT000597 | 0.14 | Protein ratios | Granulosa cell | 29 | 1 | 6 | 9 | |
| 1597 | Stomach and duodenal disorder | GASTR000053 | 0.14 | Gastrointestinal | Muscle / cardiac | 6 | 4 | 7 | 18 | |
| 1598 | BPIFB2 levels | PROLV000211 | 0.14 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 1599 | VASN levels | PROLV002151 | 0.14 | Protein levels | Hepatocyte | 136 | 1 | 7 | 11 | |
| 1600 | PCSK9 levels | PROLV001512 | 0.14 | Protein levels | Hepatocyte | 87 | 1 | 5 | 8 | |
| 1601 | BAG6/USP8 ratio | PRORT000201 | 0.14 | Protein ratios | Hepatocyte | 4 | 4 | 9 | 21 | |
| 1602 | STX8/USP8 ratio | PRORT001821 | 0.14 | Protein ratios | Hepatocyte | 0 | 2 | 7 | 11 | |
| 1603 | DNPH1/PDGFB ratio | PRORT000936 | 0.14 | Protein ratios | Hepatocyte | 5 | 4 | 7 | 23 | |
| 1604 | NFU1 levels | PROLV001400 | 0.14 | Protein levels | Stromal / connective | 2 | 3 | 7 | 16 | |
| 1605 | Pyloric stenosis | GASTR000052 | 0.14 | Gastrointestinal | B / plasma cell | 0 | 0 | 6 | 6 | |
| 1606 | Reticulocyte | HEMAT000013 | 0.14 | Hematologic | Platelet | 1,657 | 4 | 2 | 9 | |
| 1607 | Cancer, Lip | MALIG000017 | 0.14 | Malignancy | Lymphocyte | 0 | 3 | 11 | 39 | |
| 1608 | NTRK3 levels | PROLV001448 | 0.14 | Protein levels | Myeloid | 68 | 2 | 4 | 7 | |
| 1609 | Diabetes, type 1 | IMMUN000012 | 0.14 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 1610 | Medication, ACE inhibitor | VASCU000028 | 0.14 | Vascular | Vascular | 12 | 0 | 2 | 3 | |
| 1611 | F13B levels | PROLV000744 | 0.13 | Protein levels | Myeloid | 36 | 3 | 14 | 18 | |
| 1612 | HSPG2/PTGDS ratio | PRORT001308 | 0.13 | Protein ratios | Vascular | 14 | 3 | 14 | 21 | |
| 1613 | GCHFR levels | PROLV000867 | 0.13 | Protein levels | Hepatocyte | 2 | 2 | 13 | 40 | |
| 1614 | RHOC/TBCC ratio | PRORT001741 | 0.13 | Protein ratios | Myeloid | 0 | 4 | 10 | 12 | |
| 1615 | RPE levels | PROLV001753 | 0.13 | Protein levels | Lymphocyte | 0 | 2 | 15 | 29 | |
| 1616 | ADAMTSL4 levels | PROLV000037 | 0.13 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 1617 | IBD-Crohn disease | IMMUN000029 | 0.13 | Immunologic | Myeloid | 279 | 4 | 19 | 18 | |
| 1618 | ITGBL1 levels | PROLV001117 | 0.13 | Protein levels | Vascular | 82 | 3 | 11 | 14 | |
| 1619 | EDAR levels | PROLV000674 | 0.13 | Protein levels | Hematopoietic progenitor | 11 | 2 | 4 | 9 | |
| 1620 | LAYN/TNFRSF4 ratio | PRORT001434 | 0.13 | Protein ratios | Myeloid | 8 | 3 | 7 | 11 | |
| 1621 | APOA1 levels | PROLV000117 | 0.13 | Protein levels | Hepatocyte | 792 | 3 | 9 | 16 | |
| 1622 | Pyruvate | METAB000069 | 0.13 | Metabolites | Hematopoietic progenitor | 6 | 1 | 3 | 6 | |
| 1623 | PRSS22 levels | PROLV001645 | 0.13 | Protein levels | Renal epithelium | 38 | 0 | 3 | 6 | |
| 1624 | DNM3 levels | PROLV000639 | 0.13 | Protein levels | Hematopoietic progenitor | 17 | 1 | 2 | 10 | |
| 1625 | PDGFB/SPARC ratio | PRORT001645 | 0.13 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 1626 | FADD levels | PROLV000758 | 0.13 | Protein levels | Stromal / connective | 13 | 3 | 5 | 15 | |
| 1627 | Histidine | METAB000023 | 0.13 | Metabolites | Hepatocyte | 171 | 1 | 4 | 8 | |
| 1628 | Bilirubin metabolism disorder | HPBIL000003 | 0.13 | Hepatopancreatobiliary | Hepatocyte | 20 | 2 | 9 | 16 | |
| 1629 | IBD-Ulcerative colitis, with PSC | IMMUN000016 | 0.13 | Immunologic | Myeloid | 38 | 5 | 13 | 25 | |
| 1630 | Central serous chorioretinopathy | OPHTH000035 | 0.13 | Ophthalmic | Hepatocyte | 11 | 2 | 5 | 15 | |
| 1631 | CPB1/PRSS2 ratio | PRORT000727 | 0.12 | Protein ratios | Granulosa cell | 22 | 0 | 1 | 6 | |
| 1632 | CLEC1B/RWDD1 ratio | PRORT000648 | 0.12 | Protein ratios | Hepatocyte | 7 | 3 | 7 | 15 | |
| 1633 | Nephritis and nephropathy | NEPHR000010 | 0.12 | Nephrourologic | Muscle / cardiac | 0 | 1 | 4 | 7 | |
| 1634 | DKK4/REG1A ratio | PRORT000909 | 0.12 | Protein ratios | Hepatocyte | 32 | 2 | 8 | 16 | |
| 1635 | MPI levels | PROLV001334 | 0.12 | Protein levels | Stromal / connective | 10 | 5 | 10 | 15 | |
| 1636 | NCAM1 levels | PROLV001377 | 0.12 | Protein levels | Muscle / cardiac | 119 | 4 | 11 | 24 | |
| 1637 | SERPINA5 levels | PROLV001819 | 0.12 | Protein levels | Hepatocyte | 98 | 1 | 5 | 10 | |
| 1638 | MOG/SEZ6L ratio | PRORT001553 | 0.12 | Protein ratios | Myeloid | 7 | 2 | 9 | 13 | |
| 1639 | SEPHS1 levels | PROLV001812 | 0.12 | Protein levels | Neural / glial | 0 | 2 | 6 | 8 | |
| 1640 | NID1/NID2 ratio | PRORT001588 | 0.12 | Protein ratios | Lymphocyte | 3 | 3 | 8 | 25 | |
| 1641 | C2/SSC5D ratio | PRORT000265 | 0.12 | Protein ratios | Vascular | 15 | 1 | 6 | 10 | |
| 1642 | HAO1 levels | PROLV000951 | 0.12 | Protein levels | Hepatocyte | 87 | 1 | 6 | 9 | |
| 1643 | PNLIP levels | PROLV001591 | 0.12 | Protein levels | Pancreatic epithelium | 103 | 0 | 2 | 8 | |
| 1644 | APOA levels | PROLV000116 | 0.12 | Protein levels | Hepatocyte | 1,456 | 3 | 9 | 17 | |
| 1645 | EBAG9/EDAR ratio | PRORT000957 | 0.12 | Protein ratios | Myeloid | 27 | 4 | 12 | 16 | |
| 1646 | AKT1S1/MAX ratio | PRORT000065 | 0.12 | Protein ratios | Myeloid | 3 | 3 | 10 | 12 | |
| 1647 | Fatty acids ratio | LIPID000031 | 0.12 | Lipids | Hepatocyte | 426 | 2 | 8 | 18 | |
| 1648 | PLIN1/SNCG ratio | PRORT001681 | 0.12 | Protein ratios | Muscle / cardiac | 4 | 1 | 4 | 4 | |
| 1649 | IL18RAP levels | PROLV001057 | 0.12 | Protein levels | B / plasma cell | 20 | 2 | 5 | 6 | |
| 1650 | CLMP/PIK3IP1 ratio | PRORT000669 | 0.12 | Protein ratios | Adipose | 1 | 3 | 6 | 10 | |
| 1651 | STX4 levels | PROLV001968 | 0.12 | Protein levels | Vascular | 9 | 3 | 8 | 15 | |
| 1652 | Lipoprotein particles, VLDL | LIPID000046 | 0.12 | Lipids | Hepatocyte | 1,175 | 2 | 8 | 20 | |
| 1653 | Sjogren syndrome | IMMUN000043 | 0.12 | Immunologic | Lymphocyte | 33 | 2 | 11 | 18 | |
| 1654 | LAG3/VCAM1 ratio | PRORT001418 | 0.12 | Protein ratios | Hepatocyte | 24 | 4 | 13 | 36 | |
| 1655 | Glutamate metabolites | METAB000005 | 0.12 | Metabolites | Vascular | 0 | 0 | 2 | 5 | |
| 1656 | CD99L2/CPM ratio | PRORT000538 | 0.11 | Protein ratios | Hepatocyte | 28 | 2 | 10 | 16 | |
| 1657 | BTN2A1/LILRB4 ratio | PRORT000258 | 0.11 | Protein ratios | Myeloid | 77 | 3 | 10 | 14 | |
| 1658 | Male genital disorder | REPRO000013 | 0.11 | Reproductive | Granulosa cell | 7 | 0 | 7 | 9 | |
| 1659 | Gestational hypertension | VASCU000045 | 0.11 | Vascular | Lymphocyte | 3 | 1 | 7 | 22 | |
| 1660 | PLIN3 levels | PROLV001579 | 0.11 | Protein levels | Muscle / cardiac | 0 | 6 | 11 | 22 | |
| 1661 | APOB/APOA1 ratio | PRORT000117 | 0.11 | Protein ratios | Hepatocyte | 343 | 1 | 9 | 14 | |
| 1662 | LPCAT2 levels | PROLV001221 | 0.11 | Protein levels | Hepatocyte | 0 | 1 | 4 | 18 | |
| 1663 | Cancer, Bladder | MALIG000009 | 0.11 | Malignancy | Cutaneous epithelium | 3 | 0 | 11 | 8 | |
| 1664 | PTH1R levels | PROLV001668 | 0.11 | Protein levels | Stromal / connective | 30 | 2 | 6 | 9 | |
| 1665 | CA13 levels | PROLV000242 | 0.11 | Protein levels | Platelet | 19 | 3 | 4 | 16 | |
| 1666 | Muscular dystrophy | MSKEL000028 | 0.11 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 1667 | SLC35G2 levels | PROLV001879 | 0.11 | Protein levels | Neural / glial | 0 | 2 | 4 | 6 | |
| 1668 | PDGFC/TFPI ratio | PRORT001653 | 0.11 | Protein ratios | Hepatocyte | 52 | 2 | 12 | 21 | |
| 1669 | CTRB1 levels | PROLV000557 | 0.11 | Protein levels | Pancreatic epithelium | 159 | 0 | 3 | 4 | |
| 1670 | FKBP1B/TGFB1 ratio | PRORT001152 | 0.11 | Protein ratios | Myeloid | 4 | 3 | 12 | 26 | |
| 1671 | MED18 levels | PROLV001292 | 0.11 | Protein levels | Myeloid | 23 | 5 | 10 | 12 | |
| 1672 | SNX5 levels | PROLV001914 | 0.11 | Protein levels | Myeloid | 6 | 3 | 11 | 24 | |
| 1673 | GMFG levels | PROLV000901 | 0.11 | Protein levels | Myeloid | 17 | 4 | 9 | 23 | |
| 1674 | Tooth agenesis | DENTA000003 | 0.11 | Dental | Epithelial | 0 | 0 | 7 | 14 | |
| 1675 | CDH17/PECAM1 ratio | PRORT000549 | 0.11 | Protein ratios | Myeloid | 16 | 1 | 11 | 17 | |
| 1676 | HNRNPUL1 levels | PROLV000983 | 0.11 | Protein levels | Lymphocyte | 15 | 4 | 11 | 41 | |
| 1677 | Urolithiasis | NEPHR000026 | 0.11 | Nephrourologic | Epithelial | 279 | 1 | 6 | 12 | |
| 1678 | KLK11 levels | PROLV001152 | 0.11 | Protein levels | Myeloid | 26 | 1 | 4 | 12 | |
| 1679 | PRSS2 levels | PROLV001644 | 0.11 | Protein levels | Pancreatic epithelium | 76 | 0 | 6 | 7 | |
| 1680 | CRTAM/FCRL6 ratio | PRORT000768 | 0.11 | Protein ratios | Lymphocyte | 37 | 2 | 12 | 22 | |
| 1681 | CDH17/DSG2 ratio | PRORT000547 | 0.11 | Protein ratios | Lymphocyte | 8 | 0 | 3 | 8 | |
| 1682 | CELA2A levels | PROLV000396 | 0.11 | Protein levels | Pancreatic epithelium | 122 | 0 | 5 | 8 | |
| 1683 | MESD/VASH1 ratio | PRORT001518 | 0.11 | Protein ratios | Adipose | 9 | 4 | 9 | 19 | |
| 1684 | CLEC1B/NSFL1C ratio | PRORT000645 | 0.10 | Protein ratios | Myeloid | 9 | 3 | 8 | 16 | |
| 1685 | CPA1 levels | PROLV000501 | 0.10 | Protein levels | Pancreatic epithelium | 139 | 0 | 6 | 6 | |
| 1686 | AK1/NSFL1C ratio | PRORT000062 | 0.10 | Protein ratios | Hepatocyte | 0 | 2 | 5 | 21 | |
| 1687 | CD79B/ICAM3 ratio | PRORT000512 | 0.10 | Protein ratios | B / plasma cell | 22 | 2 | 8 | 6 | |
| 1688 | GPKOW levels | PROLV000925 | 0.10 | Protein levels | Muscle / cardiac | 5 | 4 | 5 | 17 | |
| 1689 | EPO/TFRC ratio | PRORT001040 | 0.10 | Protein ratios | Lymphocyte | 0 | 4 | 7 | 15 | |
| 1690 | MASP1 levels | PROLV001276 | 0.10 | Protein levels | Hepatocyte | 99 | 1 | 7 | 7 | |
| 1691 | MAX/STK24 ratio | PRORT001503 | 0.10 | Protein ratios | Myeloid | 0 | 4 | 7 | 11 | |
| 1692 | CSF2 levels | PROLV000538 | 0.10 | Protein levels | Muscle / cardiac | 12 | 1 | 2 | 21 | |
| 1693 | Haemoglobin status | HEMAT000009 | 0.10 | Hematologic | Stromal / connective | 1 | 1 | 2 | 6 | |
| 1694 | Medication, antispasmodic | GASTR000015 | 0.10 | Gastrointestinal | Lymphocyte | 0 | 3 | 9 | 27 | |
| 1695 | SRP14 levels | PROLV001943 | 0.10 | Protein levels | Lymphocyte | 4 | 2 | 14 | 26 | |
| 1696 | STAT5B levels | PROLV001959 | 0.10 | Protein levels | Myeloid | 29 | 5 | 12 | 20 | |
| 1697 | CLPP levels | PROLV000462 | 0.10 | Protein levels | Myeloid | 2 | 4 | 5 | 17 | |
| 1698 | ECHDC3 levels | PROLV000670 | 0.10 | Protein levels | Hepatocyte | 45 | 2 | 7 | 7 | |
| 1699 | Family history, Alzheimer disease | NEURO000007 | 0.10 | Neurologic | Vascular | 35 | 0 | 1 | 3 | |
| 1700 | CNDP1 levels | PROLV000471 | 0.10 | Protein levels | Hepatocyte | 75 | 2 | 12 | 12 | |
| 1701 | Medication, dysmenorrhea | REPRO000018 | 0.10 | Reproductive | Myeloid | 11 | 0 | 4 | 8 | |
| 1702 | Hair pigmentation | DERMA000025 | 0.10 | Dermatologic | Melanocyte | 189 | 2 | 7 | 22 | |
| 1703 | DOK2/GRAP2 ratio | PRORT000938 | 0.10 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 4 | 7 | |
| 1704 | HEXIM1/TBL1X ratio | PRORT001280 | 0.10 | Protein ratios | Myeloid | 4 | 3 | 12 | 30 | |
| 1705 | EGLN1/PIK3AP1 ratio | PRORT001004 | 0.10 | Protein ratios | Myeloid | 2 | 2 | 6 | 9 | |
| 1706 | CAMK1D levels | PROLV000259 | 0.10 | Protein levels | Hepatocyte | 9 | 2 | 8 | 12 | |
| 1707 | MAP2K1 levels | PROLV001266 | 0.10 | Protein levels | Lymphocyte | 23 | 3 | 11 | 34 | |
| 1708 | GALNT10/IGSF3 ratio | PRORT001201 | 0.10 | Protein ratios | Hepatocyte | 8 | 3 | 11 | 21 | |
| 1709 | CTRL levels | PROLV000559 | 0.10 | Protein levels | Hepatocyte | 128 | 1 | 3 | 7 | |
| 1710 | PVR levels | PROLV001687 | 0.10 | Protein levels | Hepatocyte | 54 | 1 | 9 | 10 | |
| 1711 | Medication, antithrombotic | VASCU000033 | 0.09 | Vascular | Vascular | 37 | 4 | 10 | 12 | |
| 1712 | APOM/MCAM ratio | PRORT000119 | 0.09 | Protein ratios | Hepatocyte | 64 | 2 | 10 | 18 | |
| 1713 | GLO1 levels | PROLV000895 | 0.09 | Protein levels | Lymphocyte | 0 | 2 | 7 | 31 | |
| 1714 | PDGFB/SNAP29 ratio | PRORT001644 | 0.09 | Protein ratios | Myeloid | 15 | 2 | 12 | 13 | |
| 1715 | FGF19 levels | PROLV000793 | 0.09 | Protein levels | Hepatocyte | 49 | 1 | 7 | 22 | |
| 1716 | DIABLO/PDGFB ratio | PRORT000892 | 0.09 | Protein ratios | Myeloid | 1 | 4 | 10 | 17 | |
| 1717 | Follicle-stimulating hormone, FSH | ENDOC000005 | 0.09 | Endocrine | Myeloid | 0 | 3 | 10 | 10 | |
| 1718 | Medication, benign prostatic hyperplasia | REPRO000017 | 0.09 | Reproductive | Respiratory epithelium | 14 | 0 | 4 | 4 | |
| 1719 | Bacterial infections | IMMUN000051 | 0.09 | Immunologic | Myeloid | 17 | 5 | 13 | 30 | |
| 1720 | DOK2/PDLIM7 ratio | PRORT000940 | 0.09 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 1721 | Mosaic chromosomal alteration | MISCL000014 | 0.09 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 1722 | Hair characteristics | DERMA000031 | 0.09 | Dermatologic | Adipose | 1 | 1 | 1 | 0 | |
| 1723 | MUC13 levels | PROLV001351 | 0.09 | Protein levels | Vascular | 23 | 1 | 10 | 14 | |
| 1724 | ITGB1/TFPI ratio | PRORT001381 | 0.09 | Protein ratios | Hepatocyte | 52 | 1 | 14 | 13 | |
| 1725 | CXCL1 levels | PROLV000575 | 0.09 | Protein levels | Granulosa cell | 44 | 2 | 6 | 9 | |
| 1726 | Total lipids, VLDL | LIPID000077 | 0.09 | Lipids | Hepatocyte | 1,057 | 2 | 8 | 17 | |
| 1727 | GBP6 levels | PROLV000863 | 0.09 | Protein levels | Hepatocyte | 11 | 2 | 9 | 14 | |
| 1728 | EFEMP1/TGFBR3 ratio | PRORT000988 | 0.09 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 1729 | THBD levels | PROLV002025 | 0.09 | Protein levels | Vascular | 104 | 1 | 4 | 11 | |
| 1730 | MMP13 levels | PROLV001324 | 0.09 | Protein levels | Stromal / connective | 0 | 1 | 4 | 5 | |
| 1731 | SIL1 levels | PROLV001866 | 0.09 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 1732 | FSTL3/SPON2 ratio | PRORT001182 | 0.09 | Protein ratios | Hepatocyte | 3 | 2 | 9 | 23 | |
| 1733 | HGF/PDGFB ratio | PRORT001284 | 0.09 | Protein ratios | Hepatocyte | 11 | 2 | 6 | 17 | |
| 1734 | CASP3/PDGFA ratio | PRORT000316 | 0.09 | Protein ratios | Myeloid | 9 | 4 | 11 | 16 | |
| 1735 | Operation, respiratory | RESPI000025 | 0.09 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 1736 | CEP170 levels | PROLV000400 | 0.09 | Protein levels | Myeloid | 1 | 1 | 5 | 11 | |
| 1737 | TGFB1 levels | PROLV002020 | 0.09 | Protein levels | Myeloid | 54 | 2 | 7 | 8 | |
| 1738 | SERPINC1 levels | PROLV001828 | 0.09 | Protein levels | Hepatocyte | 51 | 1 | 7 | 16 | |
| 1739 | Heart disease | CARDI000036 | 0.09 | Cardiac | Muscle / cardiac | 66 | 4 | 8 | 25 | |
| 1740 | Allergic rhinitis | IMMUN000004 | 0.09 | Immunologic | Lymphocyte | 125 | 2 | 14 | 18 | |
| 1741 | CD40 levels | PROLV000340 | 0.09 | Protein levels | Platelet | 9 | 1 | 2 | 4 | |
| 1742 | Cancer, Pancreas | MALIG000025 | 0.09 | Malignancy | Myeloid | 0 | 0 | 5 | 4 | |
| 1743 | CA1/TGM2 ratio | PRORT000270 | 0.09 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 1744 | Hypercalcaemia | METBL000005 | 0.09 | Metabolic | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 1745 | NPHS2 levels | PROLV001422 | 0.09 | Protein levels | B / plasma cell | 1 | 0 | 3 | 7 | |
| 1746 | ADAMTS4 levels | PROLV000034 | 0.09 | Protein levels | Lymphocyte | 3 | 2 | 12 | 23 | |
| 1747 | Arthropathy, enteropathic | IMMUN000009 | 0.09 | Immunologic | Lymphocyte | 10 | 0 | 3 | 15 | |
| 1748 | DEFA1_DEFA1B/LCN2 ratio | PRORT000885 | 0.08 | Protein ratios | Myeloid | 58 | 4 | 9 | 16 | |
| 1749 | MAMDC4 levels | PROLV001259 | 0.08 | Protein levels | Hepatocyte | 46 | 2 | 7 | 11 | |
| 1750 | HPCAL1/LAT ratio | PRORT001295 | 0.08 | Protein ratios | Myeloid | 21 | 3 | 10 | 13 | |
| 1751 | MCAM/NTRK3 ratio | PRORT001506 | 0.08 | Protein ratios | Vascular | 17 | 2 | 8 | 14 | |
| 1752 | Optic disc morphology | OPHTH000030 | 0.08 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 1753 | COX5B/FXN ratio | PRORT000715 | 0.08 | Protein ratios | Melanocyte | 0 | 2 | 3 | 6 | |
| 1754 | KLK4 levels | PROLV001156 | 0.08 | Protein levels | Hepatocyte | 34 | 2 | 7 | 11 | |
| 1755 | Gastrointestinal polyps | GASTR000005 | 0.08 | Gastrointestinal | Respiratory epithelium | 0 | 0 | 4 | 11 | |
| 1756 | GSTA1/KRT18 ratio | PRORT001249 | 0.08 | Protein ratios | Hepatocyte | 13 | 2 | 7 | 12 | |
| 1757 | THOP1 levels | PROLV002028 | 0.08 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 1758 | SERPINI2 levels | PROLV001837 | 0.08 | Protein levels | Pancreatic epithelium | 137 | 0 | 2 | 3 | |
| 1759 | NID1/TIMP3 ratio | PRORT001590 | 0.08 | Protein ratios | Vascular | 24 | 1 | 7 | 11 | |
| 1760 | CCBL2 levels | PROLV000274 | 0.08 | Protein levels | Neural / glial | 0 | 0 | 7 | 13 | |
| 1761 | FADD/MGLL ratio | PRORT001105 | 0.08 | Protein ratios | Hematopoietic progenitor | 12 | 0 | 4 | 12 | |
| 1762 | C7 levels | PROLV000236 | 0.08 | Protein levels | Adipose | 12 | 2 | 11 | 27 | |
| 1763 | DBNL/VASH1 ratio | PRORT000869 | 0.08 | Protein ratios | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 1764 | Peak expiratory flow | RESPI000023 | 0.08 | Respiratory | Stromal / connective | 305 | 2 | 5 | 8 | |
| 1765 | TNFRSF10A levels | PROLV002057 | 0.08 | Protein levels | Myeloid | 46 | 1 | 7 | 5 | |
| 1766 | AGXT/GSTA1 ratio | PRORT000052 | 0.08 | Protein ratios | Hepatocyte | 24 | 1 | 7 | 7 | |
| 1767 | Xenobiotic metabolites | METAB000080 | 0.08 | Metabolites | Hepatocyte | 26 | 1 | 3 | 11 | |
| 1768 | MMP7 levels | PROLV001326 | 0.08 | Protein levels | Hepatocyte | 5 | 1 | 11 | 22 | |
| 1769 | KLK8 levels | PROLV001159 | 0.08 | Protein levels | Myeloid | 29 | 2 | 9 | 14 | |
| 1770 | F7/F9 ratio | PRORT001087 | 0.08 | Protein ratios | Hepatocyte | 55 | 1 | 12 | 14 | |
| 1771 | CRLF1 levels | PROLV000527 | 0.08 | Protein levels | Hepatocyte | 48 | 3 | 11 | 17 | |
| 1772 | LTBP2/PDGFRA ratio | PRORT001465 | 0.08 | Protein ratios | Myeloid | 4 | 3 | 9 | 8 | |
| 1773 | SPOCK2 levels | PROLV001935 | 0.08 | Protein levels | Hepatocyte | 5 | 2 | 6 | 12 | |
| 1774 | BPIFB1/GLRX ratio | PRORT000245 | 0.08 | Protein ratios | Adipose | 0 | 4 | 9 | 18 | |
| 1775 | MVK/SERPINE1 ratio | PRORT001565 | 0.08 | Protein ratios | Platelet | 10 | 3 | 16 | 31 | |
| 1776 | ITIH3 levels | PROLV001118 | 0.08 | Protein levels | Myeloid | 106 | 3 | 9 | 13 | |
| 1777 | ASGR1/GGT5 ratio | PRORT000148 | 0.08 | Protein ratios | Hepatocyte | 60 | 1 | 9 | 18 | |
| 1778 | PRDX5 levels | PROLV001626 | 0.08 | Protein levels | Stromal / connective | 15 | 4 | 10 | 16 | |
| 1779 | Haemorrhoidal disease | VASCU000062 | 0.08 | Vascular | Vascular | 67 | 4 | 9 | 16 | |
| 1780 | Total lipids, lipoprotein particles | LIPID000078 | 0.08 | Lipids | Hepatocyte | 314 | 1 | 7 | 15 | |
| 1781 | EBAG9/HBEGF ratio | PRORT000959 | 0.08 | Protein ratios | Myeloid | 37 | 3 | 14 | 15 | |
| 1782 | Glycosylceramides | LIPID000069 | 0.08 | Lipids | Myeloid | 1 | 1 | 9 | 16 | |
| 1783 | SFTPD levels | PROLV001849 | 0.08 | Protein levels | Vascular | 77 | 1 | 5 | 14 | |
| 1784 | IZUMO4 levels | PROLV001123 | 0.08 | Protein levels | Myeloid | 2 | 3 | 10 | 21 | |
| 1785 | AKT3 levels | PROLV000076 | 0.08 | Protein levels | Platelet | 10 | 5 | 10 | 16 | |
| 1786 | TNFRSF13C levels | PROLV002064 | 0.08 | Protein levels | B / plasma cell | 45 | 3 | 7 | 22 | |
| 1787 | MAPRE3 levels | PROLV001273 | 0.08 | Protein levels | Lymphocyte | 67 | 3 | 16 | 32 | |
| 1788 | Eyelid disorder | OPHTH000019 | 0.08 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 1789 | Fatty acids, linoleic acid | LIPID000022 | 0.08 | Lipids | Hepatocyte | 920 | 2 | 7 | 11 | |
| 1790 | LBP levels | PROLV001188 | 0.08 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 1791 | FURIN/INHBC ratio | PRORT001184 | 0.07 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 23 | |
| 1792 | EPHB6/TNFRSF9 ratio | PRORT001038 | 0.07 | Protein ratios | Myeloid | 23 | 3 | 15 | 47 | |
| 1793 | Metabolic disorder | METBL000014 | 0.07 | Metabolic | Hepatocyte | 114 | 1 | 7 | 15 | |
| 1794 | Glaucoma | OPHTH000009 | 0.07 | Ophthalmic | Stromal / connective | 407 | 3 | 7 | 9 | |
| 1795 | Triglycerides, LDL | LIPID000035 | 0.07 | Lipids | Hepatocyte | 1,174 | 2 | 10 | 12 | |
| 1796 | BCR/ICA1 ratio | PRORT000226 | 0.07 | Protein ratios | Hepatocyte | 0 | 1 | 4 | 23 | |
| 1797 | Amino acid metabolism disorder | METBL000001 | 0.07 | Metabolic | Lymphocyte | 0 | 2 | 3 | 9 | |
| 1798 | Macular puckering of retina | OPHTH000037 | 0.07 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 1799 | Medication, anti-gout | METBL000025 | 0.07 | Metabolic | Hepatocyte | 167 | 1 | 4 | 9 | |
| 1800 | LGALS7_LGALS7B/WFDC12 ratio | PRORT001452 | 0.07 | Protein ratios | Respiratory epithelium | 4 | 0 | 18 | 12 | |
| 1801 | CTRC levels | PROLV000558 | 0.07 | Protein levels | Pancreatic epithelium | 90 | 0 | 1 | 3 | |
| 1802 | BCR/VASH1 ratio | PRORT000230 | 0.07 | Protein ratios | Hepatocyte | 1 | 1 | 6 | 13 | |
| 1803 | PTPRR levels | PROLV001680 | 0.07 | Protein levels | Epithelial | 0 | 0 | 7 | 15 | |
| 1804 | DIPK2B levels | PROLV000619 | 0.07 | Protein levels | Vascular | 85 | 4 | 10 | 22 | |
| 1805 | Myocardial infarction | CARDI000042 | 0.07 | Cardiac | Vascular | 343 | 3 | 9 | 12 | |
| 1806 | DAG1/HBEGF ratio | PRORT000848 | 0.07 | Protein ratios | Myeloid | 61 | 2 | 10 | 15 | |
| 1807 | Anal and rectal disorder | GASTR000001 | 0.07 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 1808 | Medication, laxative | GASTR000016 | 0.07 | Gastrointestinal | Myeloid | 0 | 2 | 4 | 15 | |
| 1809 | PPT1 levels | PROLV001621 | 0.07 | Protein levels | Melanocyte | 2 | 3 | 7 | 26 | |
| 1810 | Congenital malformation | REPRO000003 | 0.07 | Reproductive | Lymphocyte | 8 | 2 | 5 | 14 | |
| 1811 | MAD1L1/POLR2F ratio | PRORT001475 | 0.07 | Protein ratios | Myeloid | 0 | 4 | 10 | 14 | |
| 1812 | IFNGR1/THBD ratio | PRORT001332 | 0.07 | Protein ratios | Vascular | 22 | 3 | 9 | 14 | |
| 1813 | EFNB2 levels | PROLV000683 | 0.07 | Protein levels | Hepatocyte | 9 | 0 | 3 | 6 | |
| 1814 | MYOM2 levels | PROLV001364 | 0.07 | Protein levels | Muscle / cardiac | 0 | 3 | 5 | 9 | |
| 1815 | AXIN1/IKBKG ratio | PRORT000171 | 0.07 | Protein ratios | Muscle / cardiac | 10 | 5 | 13 | 29 | |
| 1816 | Lactate | METAB000066 | 0.07 | Metabolites | Myeloid | 0 | 1 | 5 | 10 | |
| 1817 | LAMA4 levels | PROLV001178 | 0.07 | Protein levels | Vascular | 67 | 2 | 8 | 19 | |
| 1818 | CCL20 levels | PROLV000287 | 0.07 | Protein levels | Myeloid | 32 | 1 | 3 | 2 | |
| 1819 | EPCAM levels | PROLV000715 | 0.07 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 1820 | PSME1 levels | PROLV001658 | 0.07 | Protein levels | Stromal / connective | 0 | 3 | 9 | 18 | |
| 1821 | Keloid and scarring | DERMA000041 | 0.07 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 1822 | SEMA4C levels | PROLV001809 | 0.07 | Protein levels | Hepatocyte | 20 | 4 | 17 | 38 | |
| 1823 | CRKL/PLA2G4A ratio | PRORT000766 | 0.07 | Protein ratios | Hepatocyte | 7 | 2 | 10 | 16 | |
| 1824 | PROC levels | PROLV001637 | 0.07 | Protein levels | Hepatocyte | 164 | 2 | 6 | 14 | |
| 1825 | CD58/ROR1 ratio | PRORT000478 | 0.07 | Protein ratios | Hepatocyte | 0 | 3 | 15 | 30 | |
| 1826 | Tuberculosis, TB | IMMUN000050 | 0.07 | Immunologic | Muscle / cardiac | — | 3 | 8 | 12 | |
| 1827 | CELA3A/CPA1 ratio | PRORT000593 | 0.07 | Protein ratios | Granulosa cell | 40 | 2 | 4 | 6 | |
| 1828 | F10 levels | PROLV000740 | 0.07 | Protein levels | Hepatocyte | 80 | 3 | 10 | 14 | |
| 1829 | A1BG levels | PROLV000001 | 0.07 | Protein levels | Hepatocyte | 32 | 1 | 7 | 9 | |
| 1830 | CEP43 levels | PROLV000402 | 0.07 | Protein levels | Myeloid | 8 | 4 | 9 | 17 | |
| 1831 | CD55/PTGDS ratio | PRORT000471 | 0.07 | Protein ratios | Vascular | 1 | 3 | 8 | 21 | |
| 1832 | Non-cancer illness history | MISCL000030 | 0.07 | Miscellaneous | Lymphocyte | 34 | 2 | 11 | 17 | |
| 1833 | RAB10 levels | PROLV001695 | 0.07 | Protein levels | Myeloid | 3 | 2 | 5 | 9 | |
| 1834 | Vestibular disorder | AUDIO000022 | 0.06 | Auditory | Neural / glial | 0 | 2 | 4 | 13 | |
| 1835 | Diabetes, general | METBL000030 | 0.06 | Metabolic | Hepatocyte | 973 | 1 | 5 | 8 | |
| 1836 | CALCB levels | PROLV000256 | 0.06 | Protein levels | Myeloid | 1 | 0 | 3 | 2 | |
| 1837 | MANF levels | PROLV001262 | 0.06 | Protein levels | Myeloid | 26 | 4 | 7 | 20 | |
| 1838 | AGRP/CCN1 ratio | PRORT000049 | 0.06 | Protein ratios | Hepatocyte | 34 | 2 | 10 | 15 | |
| 1839 | PI3 levels | PROLV001554 | 0.06 | Protein levels | Cutaneous epithelium | 5 | 1 | 8 | 8 | |
| 1840 | QPCT/RNASET2 ratio | PRORT001726 | 0.06 | Protein ratios | B / plasma cell | 68 | 5 | 12 | 31 | |
| 1841 | PITHD1 levels | PROLV001563 | 0.06 | Protein levels | Vascular | 0 | 1 | 6 | 10 | |
| 1842 | CANT1/HSPB1 ratio | PRORT000307 | 0.06 | Protein ratios | Myeloid | 10 | 4 | 9 | 28 | |
| 1843 | VEGFA levels | PROLV002157 | 0.06 | Protein levels | Muscle / cardiac | 30 | 1 | 5 | 14 | |
| 1844 | Steroid metabolite | METAB000073 | 0.06 | Metabolites | Hepatocyte | 38 | 1 | 3 | 13 | |
| 1845 | CFB levels | PROLV000410 | 0.06 | Protein levels | Hepatocyte | 101 | 4 | 14 | 24 | |
| 1846 | Dermatitis and eczema | DERMA000008 | 0.06 | Dermatologic | Lymphocyte | 129 | 1 | 12 | 18 | |
| 1847 | GFER/TRIAP1 ratio | PRORT001206 | 0.06 | Protein ratios | Granulosa cell | 1 | 4 | 6 | 22 | |
| 1848 | CDH17/SPINT1 ratio | PRORT000551 | 0.06 | Protein ratios | Lymphocyte | 11 | 1 | 12 | 15 | |
| 1849 | IGFBPL1 levels | PROLV001034 | 0.06 | Protein levels | Hepatocyte | 26 | 1 | 4 | 8 | |
| 1850 | Osteochondrodysplasia | MSKEL000054 | 0.06 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 1851 | AMY2B levels | PROLV000091 | 0.06 | Protein levels | Hepatocyte | 58 | 1 | 6 | 9 | |
| 1852 | GP1BA levels | PROLV000913 | 0.06 | Protein levels | Myeloid | 60 | 5 | 12 | 17 | |
| 1853 | CRIP2/SNCG ratio | PRORT000761 | 0.06 | Protein ratios | Neural / glial | 20 | 2 | 7 | 10 | |
| 1854 | ABO levels | PROLV000007 | 0.06 | Protein levels | Muscle / cardiac | 5 | 1 | 6 | 10 | |
| 1855 | Gut microbial abundance, Rhodanobacter | GASTR000033 | 0.06 | Gastrointestinal | Hepatocyte | 0 | 2 | 18 | 46 | |
| 1856 | APP/FKBP1B ratio | PRORT000125 | 0.06 | Protein ratios | Myeloid | 0 | 4 | 15 | 21 | |
| 1857 | FAM172A levels | PROLV000762 | 0.06 | Protein levels | Stromal / connective | 9 | 2 | 9 | 24 | |
| 1858 | LECT2 levels | PROLV001196 | 0.06 | Protein levels | Hepatocyte | 66 | 1 | 6 | 7 | |
| 1859 | DLK1/PIK3IP1 ratio | PRORT000912 | 0.06 | Protein ratios | Stromal / connective | 1 | 4 | 10 | 35 | |
| 1860 | PDP1 levels | PROLV001530 | 0.06 | Protein levels | Hepatocyte | 0 | 0 | 2 | 6 | |
| 1861 | CA5A levels | PROLV000246 | 0.06 | Protein levels | Hepatocyte | 96 | 1 | 4 | 6 | |
| 1862 | CNDP1/F9 ratio | PRORT000678 | 0.06 | Protein ratios | Hepatocyte | 68 | 1 | 9 | 4 | |
| 1863 | Cardiac implants and grafts | CARDI000048 | 0.06 | Cardiac | Vascular | 36 | 4 | 9 | 23 | |
| 1864 | GABBR2 levels | PROLV000845 | 0.06 | Protein levels | B / plasma cell | 0 | 2 | 4 | 9 | |
| 1865 | ANXA3/EDAR ratio | PRORT000105 | 0.06 | Protein ratios | Myeloid | 22 | 1 | 3 | 6 | |
| 1866 | CASP3/PDGFB ratio | PRORT000317 | 0.06 | Protein ratios | Myeloid | 3 | 4 | 10 | 18 | |
| 1867 | TNFRSF13C/TNFSF13B ratio | PRORT001849 | 0.06 | Protein ratios | B / plasma cell | 32 | 3 | 7 | 28 | |
| 1868 | CD2AP/USP8 ratio | PRORT000421 | 0.06 | Protein ratios | Myeloid | 0 | 4 | 8 | 23 | |
| 1869 | OLR1 levels | PROLV001467 | 0.06 | Protein levels | Myeloid | 37 | 2 | 7 | 17 | |
| 1870 | GFAP levels | PROLV000874 | 0.06 | Protein levels | Myeloid | 2 | 3 | 11 | 10 | |
| 1871 | CDH17/PTPRM ratio | PRORT000550 | 0.06 | Protein ratios | Lymphocyte | 10 | 1 | 14 | 25 | |
| 1872 | HDGF levels | PROLV000959 | 0.06 | Protein levels | Myeloid | 18 | 3 | 7 | 12 | |
| 1873 | S100G levels | PROLV001772 | 0.06 | Protein levels | Hepatocyte | 9 | 1 | 3 | 10 | |
| 1874 | ERBIN/SNAP29 ratio | PRORT001051 | 0.06 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 18 | |
| 1875 | PDCD5 levels | PROLV001517 | 0.06 | Protein levels | Lymphocyte | 4 | 3 | 14 | 25 | |
| 1876 | Immune cell marker, B cell | HEMAT000021 | 0.06 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 1877 | FCRL3 levels | PROLV000785 | 0.06 | Protein levels | Lymphocyte | 48 | 2 | 9 | 18 | |
| 1878 | Ovarian cyst | REPRO000022 | 0.06 | Reproductive | Pancreatic epithelium | 32 | 0 | 5 | 7 | |
| 1879 | LMNB1 levels | PROLV001217 | 0.06 | Protein levels | Myeloid | 0 | 3 | 9 | 10 | |
| 1880 | PYDC1 levels | PROLV001689 | 0.06 | Protein levels | Cutaneous epithelium | 85 | 2 | 9 | 10 | |
| 1881 | CD69/CHMP1A ratio | PRORT000489 | 0.06 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 5 | 13 | |
| 1882 | MIF levels | PROLV001313 | 0.05 | Protein levels | Lymphocyte | 4 | 1 | 5 | 28 | |
| 1883 | CRADD/DARS1 ratio | PRORT000742 | 0.05 | Protein ratios | Myeloid | 2 | 2 | 11 | 12 | |
| 1884 | PIK3AP1 levels | PROLV001557 | 0.05 | Protein levels | Hematopoietic progenitor | 18 | 3 | 9 | 27 | |
| 1885 | NCK2/VASH1 ratio | PRORT001575 | 0.05 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 21 | |
| 1886 | OLR1/OSM ratio | PRORT001612 | 0.05 | Protein ratios | Myeloid | 13 | 2 | 8 | 20 | |
| 1887 | Intraocular pressure | OPHTH000011 | 0.05 | Ophthalmic | Stromal / connective | 184 | 4 | 6 | 10 | |
| 1888 | GRP levels | PROLV000934 | 0.05 | Protein levels | Granulosa cell | 6 | 2 | 3 | 7 | |
| 1889 | IL1RL1 levels | PROLV001063 | 0.05 | Protein levels | Stromal / connective | 20 | 1 | 3 | 11 | |
| 1890 | Skin eruption | DERMA000027 | 0.05 | Dermatologic | Lymphocyte | 0 | 2 | 14 | 20 | |
| 1891 | MELTF levels | PROLV001295 | 0.05 | Protein levels | Myeloid | 23 | 3 | 9 | 11 | |
| 1892 | APP/LAMA4 ratio | PRORT000127 | 0.05 | Protein ratios | Lymphocyte | 7 | 3 | 9 | 26 | |
| 1893 | Lens replacement | OPHTH000025 | 0.05 | Ophthalmic | Vascular | 12 | 2 | 13 | 17 | |
| 1894 | ECM1 levels | PROLV000672 | 0.05 | Protein levels | Muscle / cardiac | 18 | 4 | 13 | 49 | |
| 1895 | COQ7 levels | PROLV000498 | 0.05 | Protein levels | Hepatocyte | 59 | 1 | 6 | 7 | |
| 1896 | LCAT levels | PROLV001190 | 0.05 | Protein levels | Hepatocyte | 88 | 2 | 8 | 13 | |
| 1897 | GFER/VASH1 ratio | PRORT001207 | 0.05 | Protein ratios | Myeloid | 0 | 4 | 11 | 10 | |
| 1898 | Triglycerides | LIPID000039 | 0.05 | Lipids | Hepatocyte | 33 | 1 | 3 | 13 | |
| 1899 | MLN/TNFRSF12A ratio | PRORT001539 | 0.05 | Protein ratios | Neural / glial | 18 | 1 | 3 | 4 | |
| 1900 | CD46/THBD ratio | PRORT000460 | 0.05 | Protein ratios | Vascular | 20 | 2 | 8 | 18 | |
| 1901 | Family history, breast cancer | MALIG000038 | 0.05 | Malignancy | Myeloid | 0 | 1 | 4 | 8 | |
| 1902 | NCS1/NPY ratio | PRORT001576 | 0.05 | Protein ratios | Hepatocyte | 58 | 2 | 7 | 15 | |
| 1903 | BCL2L11/VASH1 ratio | PRORT000221 | 0.05 | Protein ratios | Hepatocyte | 33 | 2 | 8 | 14 | |
| 1904 | Citrate | METAB000065 | 0.05 | Metabolites | Hepatocyte | 316 | 2 | 9 | 21 | |
| 1905 | IRAK1/SPRY2 ratio | PRORT001369 | 0.05 | Protein ratios | Hepatocyte | 2 | 2 | 7 | 21 | |
| 1906 | ITGB1/NCAM1 ratio | PRORT001378 | 0.05 | Protein ratios | Hepatocyte | 41 | 4 | 10 | 22 | |
| 1907 | BIN1 levels | PROLV000196 | 0.05 | Protein levels | Muscle / cardiac | 0 | 2 | 10 | 18 | |
| 1908 | C2/LILRB4 ratio | PRORT000264 | 0.05 | Protein ratios | Myeloid | 71 | 3 | 11 | 24 | |
| 1909 | Spondylolisthesis or spondylolysis | MSKEL000079 | 0.05 | Musculoskeletal | Stromal / connective | 0 | 3 | 5 | 13 | |
| 1910 | TNFRSF1A levels | PROLV002068 | 0.05 | Protein levels | Stromal / connective | 42 | 0 | 7 | 7 | |
| 1911 | Lysophosphatidylinositols | LIPID000056 | 0.05 | Lipids | Hepatocyte | 3 | 2 | 5 | 20 | |
| 1912 | IRF3 levels | PROLV001100 | 0.05 | Protein levels | Neural / glial | 0 | 3 | 6 | 12 | |
| 1913 | DLK1/FAP ratio | PRORT000911 | 0.05 | Protein ratios | Adipose | 26 | 4 | 8 | 25 | |
| 1914 | Heart failure, with coronary heart disease | CARDI000005 | 0.05 | Cardiac | Stromal / connective | 54 | 3 | 9 | 17 | |
| 1915 | BCL2L11 levels | PROLV000187 | 0.05 | Protein levels | Myeloid | 90 | 2 | 7 | 17 | |
| 1916 | Menopausal disorder | REPRO000020 | 0.05 | Reproductive | Hepatocyte | 0 | 5 | 9 | 25 | |
| 1917 | CDH15 levels | PROLV000372 | 0.05 | Protein levels | Hepatocyte | 22 | 2 | 5 | 12 | |
| 1918 | Bicarbonate | METAB000042 | 0.05 | Metabolites | Renal epithelium | 656 | 1 | 6 | 6 | |
| 1919 | Creatine kinase | MSKEL000027 | 0.05 | Musculoskeletal | Muscle / cardiac | 145 | 4 | 10 | 21 | |
| 1920 | PROK1 levels | PROLV001638 | 0.05 | Protein levels | Myeloid | 74 | 2 | 15 | 17 | |
| 1921 | CX3CL1 levels | PROLV000573 | 0.05 | Protein levels | Vascular | 67 | 2 | 4 | 14 | |
| 1922 | SWAP70 levels | PROLV001983 | 0.05 | Protein levels | Hepatocyte | 3 | 2 | 9 | 12 | |
| 1923 | Aortic valve disease | CARDI000053 | 0.05 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 1924 | LAT/SERPINE1 ratio | PRORT001426 | 0.05 | Protein ratios | Myeloid | 28 | 4 | 12 | 16 | |
| 1925 | Trunk mass | BCOMP000019 | 0.05 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 1926 | Nutritional and metabolic symptoms | METBL000016 | 0.05 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 1927 | HYOU1/ROR1 ratio | PRORT001316 | 0.05 | Protein ratios | Hepatocyte | 41 | 1 | 6 | 6 | |
| 1928 | AHSA1 levels | PROLV000064 | 0.05 | Protein levels | Vascular | 1 | 0 | 2 | 16 | |
| 1929 | CDKN1A levels | PROLV000382 | 0.05 | Protein levels | Vascular | 59 | 1 | 5 | 13 | |
| 1930 | HDAC8 levels | PROLV000958 | 0.05 | Protein levels | B / plasma cell | — | 1 | 12 | 24 | |
| 1931 | Prostate-specific antigen | REPRO000041 | 0.05 | Reproductive | Salivary epithelium | 56 | 1 | 7 | 8 | |
| 1932 | SERPIND1 levels | PROLV001829 | 0.05 | Protein levels | Hepatocyte | 143 | 3 | 10 | 11 | |
| 1933 | ADH4/CA5A ratio | PRORT000038 | 0.05 | Protein ratios | Hepatocyte | 30 | 2 | 14 | 26 | |
| 1934 | Chondrocalcinosis | MSKEL000014 | 0.05 | Musculoskeletal | Vascular | 0 | 1 | 6 | 12 | |
| 1935 | CLEC1B/DIABLO ratio | PRORT000634 | 0.05 | Protein ratios | Myeloid | 2 | 3 | 8 | 17 | |
| 1936 | Liver disorder | HPBIL000011 | 0.05 | Hepatopancreatobiliary | Hepatocyte | 78 | 1 | 3 | 11 | |
| 1937 | Free androgen index | ENDOC000007 | 0.05 | Endocrine | Hepatocyte | 616 | 1 | 6 | 20 | |
| 1938 | PARK7/TNFRSF9 ratio | PRORT001621 | 0.05 | Protein ratios | Neural / glial | 8 | 3 | 6 | 18 | |
| 1939 | APOA4 levels | PROLV000119 | 0.05 | Protein levels | Granulosa cell | 12 | 0 | 5 | 7 | |
| 1940 | DKK1/MGLL ratio | PRORT000897 | 0.05 | Protein ratios | Myeloid | 9 | 4 | 10 | 23 | |
| 1941 | Fatty acids, omega-6 | LIPID000025 | 0.05 | Lipids | Hepatocyte | 1,066 | 1 | 7 | 10 | |
| 1942 | CD300LG levels | PROLV000333 | 0.05 | Protein levels | Vascular | 83 | 1 | 4 | 13 | |
| 1943 | AGXT levels | PROLV000060 | 0.05 | Protein levels | Hepatocyte | 122 | 1 | 6 | 9 | |
| 1944 | SCLY levels | PROLV001790 | 0.05 | Protein levels | Hepatocyte | 62 | 2 | 8 | 16 | |
| 1945 | Jaw relationship anomaly | DENTA000007 | 0.05 | Dental | Neural / glial | 0 | 1 | 5 | 12 | |
| 1946 | CRTAM/ICAM3 ratio | PRORT000770 | 0.05 | Protein ratios | Lymphocyte | 23 | 2 | 20 | 46 | |
| 1947 | AARSD1/PIK3AP1 ratio | PRORT000001 | 0.05 | Protein ratios | Hematopoietic progenitor | 2 | 1 | 2 | 3 | |
| 1948 | ACOX1/VSIR ratio | PRORT000013 | 0.05 | Protein ratios | Myeloid | 16 | 1 | 6 | 12 | |
| 1949 | PLA2G4A/SPINT2 ratio | PRORT001677 | 0.05 | Protein ratios | Myeloid | 16 | 4 | 10 | 23 | |
| 1950 | S100A4/SNAP29 ratio | PRORT001755 | 0.05 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 19 | |
| 1951 | CLC/RNASE3 ratio | PRORT000625 | 0.05 | Protein ratios | Myeloid | 7 | 1 | 5 | 9 | |
| 1952 | TPMT levels | PROLV002096 | 0.05 | Protein levels | Myeloid | 10 | 2 | 4 | 12 | |
| 1953 | KCNA10 levels | PROLV001130 | 0.05 | Protein levels | Stromal / connective | 0 | 1 | 1 | 8 | |
| 1954 | Otosclerosis | AUDIO000018 | 0.05 | Auditory | Granulosa cell | 16 | 5 | 10 | 16 | |
| 1955 | Otitis externa | AUDIO000003 | 0.05 | Auditory | Muscle / cardiac | 0 | 3 | 6 | 17 | |
| 1956 | CLEC1A/TNFRSF1A ratio | PRORT000632 | 0.04 | Protein ratios | Vascular | 6 | 5 | 14 | 19 | |
| 1957 | CFI levels | PROLV000418 | 0.04 | Protein levels | Myeloid | 44 | 4 | 7 | 13 | |
| 1958 | PCDH17/ROBO1 ratio | PRORT001625 | 0.04 | Protein ratios | Granulosa cell | 9 | 2 | 4 | 8 | |
| 1959 | CD27/ICAM3 ratio | PRORT000414 | 0.04 | Protein ratios | B / plasma cell | 33 | 0 | 4 | 7 | |
| 1960 | White blood cell disorder | HEMAT000019 | 0.04 | Hematologic | Lymphocyte | 2 | 3 | 10 | 35 | |
| 1961 | AGXT/GRPEL1 ratio | PRORT000051 | 0.04 | Protein ratios | Hepatocyte | 44 | 2 | 5 | 11 | |
| 1962 | KITLG levels | PROLV001146 | 0.04 | Protein levels | Hepatocyte | 114 | 2 | 5 | 6 | |
| 1963 | MET levels | PROLV001302 | 0.04 | Protein levels | Hepatocyte | 162 | 2 | 8 | 18 | |
| 1964 | OCLN levels | PROLV001461 | 0.04 | Protein levels | Lymphocyte | 0 | 3 | 6 | 39 | |
| 1965 | Fasciectomy | MSKEL000045 | 0.04 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 1966 | MERTK levels | PROLV001300 | 0.04 | Protein levels | Hepatocyte | 211 | 3 | 9 | 18 | |
| 1967 | LY6G6C levels | PROLV001247 | 0.04 | Protein levels | Hepatocyte | 1 | 4 | 8 | 14 | |
| 1968 | BCR/FOXO1 ratio | PRORT000224 | 0.04 | Protein ratios | Hepatocyte | 15 | 3 | 12 | 23 | |
| 1969 | CD40LG/EGF ratio | PRORT000449 | 0.04 | Protein ratios | Hepatocyte | 1 | 2 | 8 | 34 | |
| 1970 | CD55/CHI3L1 ratio | PRORT000469 | 0.04 | Protein ratios | Hepatocyte | 11 | 2 | 9 | 24 | |
| 1971 | YOD1 levels | PROLV002206 | 0.04 | Protein levels | Lymphocyte | 0 | 4 | 12 | 40 | |
| 1972 | CLEC4D/CLEC6A ratio | PRORT000654 | 0.04 | Protein ratios | Lymphocyte | 4 | 3 | 13 | 35 | |
| 1973 | ANKMY2 levels | PROLV000100 | 0.04 | Protein levels | Stromal / connective | 7 | 3 | 7 | 9 | |
| 1974 | ODAM levels | PROLV001462 | 0.04 | Protein levels | Salivary epithelium | 0 | 0 | 3 | 5 | |
| 1975 | MPO levels | PROLV001336 | 0.04 | Protein levels | Myeloid | 55 | 2 | 5 | 10 | |
| 1976 | PDGFA/SNAP23 ratio | PRORT001636 | 0.04 | Protein ratios | Myeloid | 9 | 2 | 15 | 16 | |
| 1977 | EDAR/PRDX5 ratio | PRORT000974 | 0.04 | Protein ratios | Myeloid | 42 | 2 | 10 | 16 | |
| 1978 | HNRNPAB levels | PROLV000981 | 0.04 | Protein levels | Granulosa cell | 11 | 3 | 8 | 17 | |
| 1979 | GDF2 levels | PROLV000870 | 0.04 | Protein levels | Hepatocyte | 160 | 1 | 7 | 15 | |
| 1980 | SERPINA9 levels | PROLV001822 | 0.04 | Protein levels | Hepatocyte | 48 | 3 | 11 | 19 | |
| 1981 | CPA1/CTRC ratio | PRORT000720 | 0.04 | Protein ratios | Pancreatic epithelium | 38 | 0 | 1 | 5 | |
| 1982 | KRT5 levels | PROLV001167 | 0.04 | Protein levels | Cutaneous epithelium | 11 | 0 | 11 | 17 | |
| 1983 | F7/PROC ratio | PRORT001088 | 0.04 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 12 | |
| 1984 | FEV1/FVC ratio | RESPI000021 | 0.04 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 1985 | Cardiac strain rate | CARDI000006 | 0.04 | Cardiac | Muscle / cardiac | 0 | 2 | 3 | 5 | |
| 1986 | CD58/MCAM ratio | PRORT000476 | 0.04 | Protein ratios | Adipose | 2 | 1 | 6 | 12 | |
| 1987 | DECR1/STX8 ratio | PRORT000884 | 0.04 | Protein ratios | Hepatocyte | 9 | 2 | 8 | 15 | |
| 1988 | NT5E levels | PROLV001441 | 0.04 | Protein levels | Hepatocyte | 96 | 1 | 10 | 9 | |
| 1989 | CRTAM/VCAM1 ratio | PRORT000775 | 0.04 | Protein ratios | Lymphocyte | 13 | 2 | 15 | 27 | |
| 1990 | ASAH1 levels | PROLV000149 | 0.04 | Protein levels | Myeloid | 48 | 6 | 13 | 26 | |
| 1991 | PRKAR1A levels | PROLV001631 | 0.04 | Protein levels | Platelet | 0 | 5 | 11 | 23 | |
| 1992 | KIR2DL3 levels | PROLV001142 | 0.04 | Protein levels | Lymphocyte | 134 | 2 | 10 | 19 | |
| 1993 | TNFRSF14 levels | PROLV002065 | 0.04 | Protein levels | Lymphocyte | 13 | 3 | 6 | 17 | |
| 1994 | Hypertensive disorders of pregnancy | VASCU000046 | 0.04 | Vascular | Vascular | 7 | 4 | 9 | 20 | |
| 1995 | VEGFD levels | PROLV002160 | 0.04 | Protein levels | Hepatocyte | 25 | 2 | 9 | 23 | |
| 1996 | Pelvic morphology | BMORP000021 | 0.04 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 1997 | NMI levels | PROLV001410 | 0.04 | Protein levels | Myeloid | 6 | 4 | 10 | 13 | |
| 1998 | CASP3/CRKL ratio | PRORT000313 | 0.04 | Protein ratios | Muscle / cardiac | 22 | 3 | 11 | 26 | |
| 1999 | F3/GFRA1 ratio | PRORT001086 | 0.04 | Protein ratios | Hepatocyte | 11 | 2 | 10 | 18 | |
| 2000 | ITGB5 levels | PROLV001114 | 0.04 | Protein levels | Platelet | 18 | 2 | 5 | 10 |